7,196 results on '"Apoptosis Regulatory Proteins genetics"'
Search Results
2. Knockdown of programmed cell death factor 4 restores erectile function by attenuating apoptosis in rats with bilateral cavernous nerve crush injury.
- Author
-
Ge Y, Xia T, Feng Z, Xi Y, Hu D, Hong Y, Tang B, Wu J, Chen J, and Xiao H
- Subjects
- Animals, Male, Rats, Nerve Crush, Gene Knockdown Techniques, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Peripheral Nerve Injuries metabolism, Apoptosis, Rats, Sprague-Dawley, Erectile Dysfunction therapy, Erectile Dysfunction etiology, Penis innervation, Penile Erection physiology
- Abstract
Background: Apoptosis is an important pathologic mechanism of erectile dysfunction after radical prostatectomy. Studies have shown that programmed cell death factor 4 is connected to the modulation of apoptosis in many cells. However, the programmed cell death factor 4 function in the cavernous nerve injury erectile dysfunction is unclear., Objective: This investigation aimed to explore the programmed cell death factor 4 function in erectile dysfunction in rats with bilateral cavernous nerve crush., Materials and Methods: The experiment used 30 male Sprague Dawley rats (18 months old) that were screened for normal erectile function by the apomorphine test. Ten rats were randomized into Sham and bilateral cavernous nerve crush groups to detect changes in programmed cell death factor 4 expression. The remaining 20 rats were distributed at random to four groups: the Sham group treated by sham surgery, the phosphate-buffered saline group, the lentivirus containing negative control short hairpin RNA group, and the lentivirus containing short hairpin RNA targeting programmed cell death factor 4 group underwent bilateral cavernous nerve crush and were afterward administered intracavernous injections of phosphate-buffered saline, lentivirus containing negative control short hairpin RNA, or lentivirus containing short hairpin RNA targeting programmed cell death factor 4. Electrical stimulation of the cavernous nerve was conducted 2 weeks later for penile erectile function assessment. The cavernous tissue was collected for histological analysis and western blotting., Results: The apoptosis level in rat corpus cavernosum was elevated, and programmed cell death factor 4 expression was increased after bilateral cavernous nerve crush. Knockdown of programmed cell death factor 4 significantly improved erectile function in bilateral cavernous nerve crush rats. Furthermore, lentivirus containing short hairpin RNA targeting programmed cell death factor 4 treatment raised smooth muscle content and attenuated cavernous fibrosis and apoptotic levels. Additionally, programmed cell death factor 4 was found to mediate the PI3K/AKT pathway., Discussion and Conclusion: Elevated programmed cell death factor 4 expression may be an important pathogenetic mechanism for erectile dysfunction after bilateral cavernous nerve crush, and the knockdown of programmed cell death factor 4 enhanced erectile function in 18-month-old rats after cavernous nerve damage. The potential mechanism may be the stimulation of the PI3K/AKT pathway to attenuate the cavernous apoptosis level., (© 2024 American Society of Andrology and European Academy of Andrology.)
- Published
- 2024
- Full Text
- View/download PDF
3. PDCD4 and MIR-21 are promising biomarkers in the follow-up of OED in liquid biopsies.
- Author
-
Arslan Bozdag L, Açik L, Ersoy HE, Bayir Ö, Korkmaz MH, Mollaoglu N, and Gultekin SE
- Subjects
- Humans, Male, Female, Middle Aged, Liquid Biopsy, Saliva chemistry, Saliva metabolism, Aged, Adult, Case-Control Studies, Precancerous Conditions genetics, Precancerous Conditions pathology, MicroRNAs blood, MicroRNAs genetics, Mouth Neoplasms genetics, Mouth Neoplasms blood, Mouth Neoplasms pathology, RNA-Binding Proteins genetics, Apoptosis Regulatory Proteins genetics, Biomarkers, Tumor genetics, Biomarkers, Tumor blood, Carcinoma, Squamous Cell genetics
- Abstract
This research aims to examine the impact of programmed cell death 4 (PDCD4), microRNA-21 (miR-21) and microRNA-208a (miR-208a) transcripts, and protein levels on oral epithelial dysplasia (OED) development in oral squamous cell carcinoma (OSCC)., Methods: The research investigation involved the collection of saliva, blood, and tissue samples from a total of 20 patients diagnosed with OSCC, 15 patients diagnosed with OED, and 15 healthy individuals. PDCD4, miR-21, and miR-208a expression was performed by quantitative reverse transcription polymerase chain reaction (qRT-PCR). PDCD4 protein levels were assessed using enzyme-linked immunosorbent assay (ELISA) in both saliva and blood samples. For statistical analysis, the Kruskal-Wallis test and the Spearmen rank test were utilised., Results: PDCD4 expression levels were considerably lower in patients with OSCC and OED (p < 0.05) in three biological samples. In contrast, miR-21 expression was higher in OED and OSCC patients. Patients with low PDCD4 mRNA levels and strong miR-21 expression had a significant connection (p < 0.05) with tumor size and depth., Conclusions: Examining PDCD4 and miR-21 transcript levels may help detect the transition from OED to OSCC. This work suggests that PDCD4 and miR-21 expression levels in liquid biopsies may be biomarkers for OED monitoring in the future., (© 2023 The Authors. Oral Diseases published by Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
4. diABZI and poly(I:C) inhibit osteoclastic bone resorption by inducing IRF7 and IFIT3.
- Author
-
Huang Y, Zhang M, Zhang J, Liu S, Li D, Qiao Z, Yao H, Shi Q, Zhou X, and Ma F
- Subjects
- Animals, Mice, Female, Mice, Inbred C57BL, Mice, Knockout, Interferon Type I metabolism, Receptor, Interferon alpha-beta metabolism, Receptor, Interferon alpha-beta genetics, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Humans, Osteolysis pathology, Osteolysis metabolism, Osteolysis drug therapy, Osteoclasts metabolism, Osteoclasts drug effects, Osteoclasts pathology, Interferon Regulatory Factor-7 metabolism, Bone Resorption pathology, Poly I-C pharmacology, Cell Differentiation drug effects
- Abstract
Type I interferons (IFN-I) are pleiotropic factors endowed with multiple activities that play important roles in innate and adaptive immunity. Although many studies indicate that IFN-I inducers exert favorable effects on broad-spectrum antivirus, immunomodulation, and anti-tumor activities by inducing endogenous IFN-I and IFN-stimulated genes, their function in bone homeostasis still needs further exploration. Here, our study demonstrates 2 distinct IFN-I inducers, diABZI and poly(I:C), as potential therapeutics to alleviate osteolysis and osteoporosis. First, IFN-I inducers suppress the genes that control osteoclast (OC) differentiation and activity in vitro. Moreover, diABZI alleviates bone loss in Ti particle-induced osteolysis and ovariectomized -induced osteoporosis in vivo by inhibiting OC differentiation and function. In addition, the inhibitory effects of IFN-I inducers on OC differentiation are not observed in macrophages derived from Ifnar1-/-mice, which indicate that the suppressive effect of IFN-I inducers on OC is IFNAR-dependent. Mechanistically, RNAi-mediated silencing of IRF7 and IFIT3 in OC precursors impairs the suppressive effect of the IFN-I inducers on OC differentiation. Taken together, these results demonstrate that IFN-I inducers play a protective role in bone turnover by limiting osteoclastogenesis and bone resorption through the induction of OC-specific mediators via the IFN-I signaling pathway., (© The Author(s) 2024. Published by Oxford University Press on behalf of the American Society for Bone and Mineral Research.)
- Published
- 2024
- Full Text
- View/download PDF
5. Acetylation-dependent deubiquitinase USP26 stabilizes BAG3 to promote breast cancer progression.
- Author
-
Liu J, Zhai M, Chen Y, Wei Y, Li F, Chen Y, Duan B, Xing L, Du H, Jiang M, Li H, and Ren G
- Subjects
- Animals, Female, Humans, Mice, Acetylation, Cell Line, Tumor, Cell Proliferation, Disease Progression, Mice, Nude, Prognosis, Protein Stability, Ubiquitination, Xenograft Model Antitumor Assays, Adaptor Proteins, Signal Transducing metabolism, Adaptor Proteins, Signal Transducing genetics, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Breast Neoplasms pathology, Breast Neoplasms genetics, Breast Neoplasms metabolism, Cysteine Endopeptidases metabolism, Cysteine Endopeptidases genetics
- Abstract
Deubiquitylases (DUBs) have emerged as promising targets for cancer therapy due to their role in stabilizing substrate proteins within the ubiquitin machinery. Here, we identified ubiquitin-specific protease 26 (USP26) as an oncogene via screening prognostic DUBs in breast cancer. Through in vitro and in vivo experiments, we found that depletion of USP26 inhibited breast cancer cell proliferation and invasion, and suppressed tumor growth and metastasis in nude mice. Further investigation identified co-chaperone Bcl-2-associated athanogene 3 (BAG3) as the direct substrate of USP26, and ectopic expression of BAG3 partially reversed antitumor effect induced by USP26 knockdown. Mechanistically, the lysine acetyltransferase Tip60 targeted USP26 at K134 for acetylation, which enhanced USP26 binding affinity to BAG3, leading to BAG3 deubiquitination and increased protein stability. Importantly, we employed a structure-based virtual screening and discovered a drug-like molecule called 5813669 that targets USP26, destabilizing BAG3 and effectively mitigating tumor growth and metastasis in vivo. Clinically, high expression levels of USP26 were correlated with elevated BAG3 levels and poor prognosis in breast cancer patients. Overall, our findings highlight the critical role of USP26 in BAG3 protein stabilization and provide a promising therapeutic target for breast cancer., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
6. Human tumor suppressor protein Pdcd4 binds at the mRNA entry channel in the 40S small ribosomal subunit.
- Author
-
Brito Querido J, Sokabe M, Díaz-López I, Gordiyenko Y, Zuber P, Du Y, Albacete-Albacete L, Ramakrishnan V, and Fraser CS
- Subjects
- Humans, Binding Sites, Protein Biosynthesis, Eukaryotic Initiation Factor-4A metabolism, Eukaryotic Initiation Factor-4A genetics, Models, Molecular, RNA-Binding Proteins metabolism, RNA-Binding Proteins genetics, RNA-Binding Proteins chemistry, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, RNA, Messenger metabolism, RNA, Messenger genetics, Ribosome Subunits, Small, Eukaryotic metabolism, Ribosome Subunits, Small, Eukaryotic genetics, Cryoelectron Microscopy, Protein Binding
- Abstract
Translation is regulated mainly in the initiation step, and its dysregulation is implicated in many human diseases. Several proteins have been found to regulate translational initiation, including Pdcd4 (programmed cell death gene 4). Pdcd4 is a tumor suppressor protein that prevents cell growth, invasion, and metastasis. It is downregulated in most tumor cells, while global translation in the cell is upregulated. To understand the mechanisms underlying translational control by Pdcd4, we used single-particle cryo-electron microscopy to determine the structure of human Pdcd4 bound to 40S small ribosomal subunit, including Pdcd4-40S and Pdcd4-40S-eIF4A-eIF3-eIF1 complexes. The structures reveal the binding site of Pdcd4 at the mRNA entry site in the 40S, where the C-terminal domain (CTD) interacts with eIF4A at the mRNA entry site, while the N-terminal domain (NTD) is inserted into the mRNA channel and decoding site. The structures, together with quantitative binding and in vitro translation assays, shed light on the critical role of the NTD for the recruitment of Pdcd4 to the ribosomal complex and suggest a model whereby Pdcd4 blocks the eIF4F-independent role of eIF4A during recruitment and scanning of the 5' UTR of mRNA., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
7. PDCD4 as a marker of mTOR pathway activation and therapeutic target in mycobacterial infections.
- Author
-
Paroha R, Wang J, and Lee S
- Subjects
- Humans, Macrophages microbiology, Macrophages immunology, Macrophages metabolism, Animals, Mice, Mycobacterium genetics, TOR Serine-Threonine Kinases metabolism, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Signal Transduction, RNA-Binding Proteins metabolism, RNA-Binding Proteins genetics, Mycobacterium Infections microbiology, Mycobacterium Infections drug therapy, Mycobacterium Infections metabolism, Mycobacterium Infections immunology, Biomarkers metabolism
- Abstract
Programmed cell death protein 4 (PDCD4) is instrumental in regulating a range of cellular processes such as translation, apoptosis, signal transduction, and inflammatory responses. There is a notable inverse correlation between PDCD4 and the mammalian target of rapamycin (mTOR) pathway, which is integral to cellular growth control. Activation of mTOR is associated with the degradation of PDCD4. Although the role of PDCD4 is well established in oncogenesis and immune response regulation, its function in mycobacterial infections and its interplay with the mTOR pathway necessitate further elucidation. This study investigates the modulation of PDCD4 expression in the context of mycobacterial infections, revealing a consistent pattern of downregulation across diverse mycobacterial species. This observation underscores the potential utility of PDCD4 as a biomarker for assessing mTOR pathway activation during such infections. Building on this finding, we employed a novel approach using PDCD4-based mTOR (Tor)-signal-indicator (TOSI) reporter cells for the high-throughput screening of FDA-approved drugs, focusing on mTOR inhibitors. This methodology facilitated the identification of several agents, inclusive of known mTOR inhibitors, which upregulated PDCD4 expression and concurrently exhibited efficacy in impeding mycobacterial proliferation within macrophages. These results not only reinforce the significance of PDCD4 as a pivotal marker in the understanding of infectious diseases, particularly mycobacterial infections, but also illuminate its potential in the identification of mTOR inhibitors, thereby contributing to the advancement of therapeutic strategies., Importance: This study emphasizes the critical role of the mammalian target of rapamycin (mTOR) pathway in macrophage responses to mycobacterial infections, elucidating how mycobacteria activate mTOR, resulting in PDCD4 degradation. The utilization of the (Tor)-signal-indicator (TOSI) vector for real-time monitoring of mTOR activity represents a significant advancement in understanding mTOR regulation during mycobacterial infection. These findings deepen our comprehension of mycobacteria's innate immune mechanisms and introduce PDCD4 as a novel marker for mTOR activity in infectious diseases. Importantly, this research laid the groundwork for high-throughput screening of mTOR inhibitors using FDA-approved drugs, offering the potential for repurposing treatments against mycobacterial infections. The identification of drugs that inhibit mTOR activation opens new avenues for host-directed therapies, marking a significant step forward in combating tuberculosis and other mycobacterial diseases., Competing Interests: The authors declare no conflict of interest.
- Published
- 2024
- Full Text
- View/download PDF
8. Comprehensive analysis of the prognostic and immunological signature of TNFAIP8 family genes in human glioma.
- Author
-
Zhang X, Zhang X, Liu T, and Sha K
- Subjects
- Humans, Apoptosis Regulatory Proteins genetics, Brain Neoplasms genetics, Brain Neoplasms immunology, Brain Neoplasms mortality, Brain Neoplasms pathology, Computational Biology methods, Mutation, Prognosis, Biomarkers, Tumor genetics, Gene Expression Regulation, Neoplastic, Glioma genetics, Glioma immunology, Glioma mortality, Glioma pathology
- Abstract
TNFAIP8 family molecules have been recognized for their involvement in the progression of tumors across a range of cancer types. Emerging experimental data suggests a role for certain TNFAIP8 family molecules in the development of glioma. Nonetheless, the comprehensive understanding of the genomic alterations, prognostic significance, and immunological profiles of TNFAIP8 family molecules in glioma remains incomplete. In the study, using the comprehensive bioinformatics tools, we explored the unique functions of 4 TNFAIP8 members including TNFAIP8, TNFAIP8L1, TNFAIP8L2 and TNFAIP8L3 in glioma. The expressions of TNFAIP8, TNFAIP8L1, TNFAIP8L2, and TNFAIP8L3 were notably upregulated in glioma tissues compared to normal tissues. Furthermore, survival analysis indicated that elevated expression levels of TNFAIP8, TNFAIP8L1 and TNFAIP8L2 were correlated with unfavorable outcomes in terms of overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI) among glioma patients. Genetic modifications, such as mutations and copy number alterations, within the TNFAIP8 family exhibited a significant association with extended OS, DSS and PFS in individuals diagnosed with glioma. The findings suggest a noteworthy correlation between TNFAIP8 family members and the age and 1p/19q codeletion status of glioma patients. We also found that there were significant relationships between TNFAIP8 family expression and tumor immunity in glioma. Furthermore, functional annotation of TNFAIP8 family members and their co-expressed genes in gliomas was carried out using GO and KEGG pathway analysis. The GO analysis revealed that the primary biological processes influenced by the TNFAIP8 family co-expressed genes included cell chemotaxis, temperature homeostasis, and endocytic vesicle formation. Additionally, the KEGG analysis demonstrated that TNFAIP8 family co-expressed genes are involved in regulating various pathways such as inflammatory mediator regulation of TRP channels, pathways in cancer, prolactin signaling pathway, and Fc gamma R-mediated phagocytosis. Overall, the findings suggest that TNFAIP8 family members may play a significant role in the development of glioma and have the potential to serve as prognostic indicators and therapeutic targets for individuals with glioma., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
9. mTORC1 Signaling in Brain Endothelial Progenitors Contributes to CCM Pathogenesis.
- Author
-
Min W, Qin L, Zhang H, López-Giráldez F, Jiang N, Kim Y, Mohan VK, Su M, Murray KN, Grutzendler J, and Zhou JH
- Subjects
- Animals, Mice, Brain metabolism, Brain pathology, Brain blood supply, Mice, Knockout, Blood-Brain Barrier metabolism, Blood-Brain Barrier pathology, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Mice, Inbred C57BL, Membrane Proteins metabolism, Membrane Proteins genetics, Signal Transduction, Hemangioma, Cavernous, Central Nervous System metabolism, Hemangioma, Cavernous, Central Nervous System genetics, Hemangioma, Cavernous, Central Nervous System pathology, Mechanistic Target of Rapamycin Complex 1 metabolism, Mechanistic Target of Rapamycin Complex 1 genetics, Endothelial Progenitor Cells metabolism, Endothelial Progenitor Cells pathology
- Abstract
Background: Cerebral vascular malformations (CCMs) are primarily found within the brain, where they result in increased risk for stroke, seizures, and focal neurological deficits. The unique feature of the brain vasculature is the blood-brain barrier formed by the brain neurovascular unit. Recent studies suggest that loss of CCM genes causes disruptions of blood-brain barrier integrity as the inciting events for CCM development. CCM lesions are proposed to be initially derived from a single clonal expansion of a subset of angiogenic venous capillary endothelial cells (ECs) and respective resident endothelial progenitor cells (EPCs). However, the critical signaling events in the subclass of brain ECs/EPCs for CCM lesion initiation and progression are unclear., Methods: Brain EC-specific CCM3-deficient ( Pdcd10
BECKO ) mice were generated by crossing Pdcd10fl/fl mice with Mfsd2a -CreERT2 mice. Single-cell RNA-sequencing analyses were performed by the chromium single-cell platform (10× genomics). Cell clusters were annotated into EC subtypes based on visual inspection and GO analyses. Cerebral vessels were visualized by 2-photon in vivo imaging and tissue immunofluorescence analyses. Regulation of mTOR (mechanistic target of rapamycin) signaling by CCM3 and Cav1 (caveolin-1) was performed by cell biology and biochemical approaches., Results: Single-cell RNA-sequencing analyses from P10 Pdcd1 0BECKO mice harboring visible CCM lesions identified upregulated CCM lesion signature and mitotic EC clusters but decreased blood-brain barrier-associated EC clusters. However, a unique EPC cluster with high expression levels of stem cell markers enriched with mTOR signaling was identified from early stages of the P6 Pdcd1 0BECKO brain. Indeed, mTOR signaling was upregulated in both mouse and human CCM lesions. Genetic deficiency of Raptor (regulatory-associated protein of mTOR), but not of Rictor (rapamycin-insensitive companion of mTOR), prevented CCM lesion formation in the Pdcd10BECKO model. Importantly, the mTORC1 (mTOR complex 1) pharmacological inhibitor rapamycin suppressed EPC proliferation and ameliorated CCM pathogenesis in Pdcd10BECKO mice. Mechanistic studies suggested that Cav1/caveolae increased in CCM3-depleted EPC-mediated intracellular trafficking and complex formation of the mTORC1 signaling proteins., Conclusions: CCM3 is critical for maintaining blood-brain barrier integrity and CCM3 loss-induced mTORC1 signaling in brain EPCs initiates and facilitates CCM pathogenesis., Competing Interests: None.- Published
- 2024
- Full Text
- View/download PDF
10. PDCD4 interacting with PIK3CB and CTSZ promotes the apoptosis of multiple myeloma cells.
- Author
-
Liu L, Feng X, Fan C, Kong D, Feng X, Sun C, Xu Y, Li B, Jiang Y, and Zheng C
- Subjects
- Animals, Humans, Male, Mice, Cell Line, Tumor, Class I Phosphatidylinositol 3-Kinases metabolism, Class I Phosphatidylinositol 3-Kinases genetics, Gene Expression Regulation, Neoplastic, X-Linked Inhibitor of Apoptosis Protein metabolism, X-Linked Inhibitor of Apoptosis Protein genetics, Apoptosis, Apoptosis Regulatory Proteins genetics, Apoptosis Regulatory Proteins metabolism, Multiple Myeloma metabolism, Multiple Myeloma genetics, Multiple Myeloma pathology, RNA-Binding Proteins metabolism, RNA-Binding Proteins genetics
- Abstract
The role of programmed cell death 4 (PDCD4) in multiple myeloma (MM) development remains unknown. Here, we investigated its role and action mechanism in MM. Bioinformatic analysis indicated that patients with MM and high PDCD4 expression had higher overall survival than those with low PDCD4 expression. PDCD4 expression promoted MM cell apoptosis and inhibited their viability in vitro and tumor growth in vivo. RNA-binding protein immunoprecipitation sequencing analysis showed that PDCD4 is bound to the 5' UTR of the apoptosis-related genes PIK3CB, Cathepsin Z (CTSZ), and X-chromosome-linked apoptosis inhibitor (XIAP). PDCD4 knockdown reduced the cell apoptosis rate, which was rescued by adding PIK3CB, CTSZ, or XIAP inhibitors. Dual luciferase reporter assays confirmed the internal ribosome entry site (IRES) activity of the 5' UTRs of PIK3CB and CTSZ. An RNA pull-down assay confirmed binding of the 5' UTR of PIK3CB and CTSZ to PDCD4, identifying the specific binding fragments. PDCD4 is expected to promote MM cell apoptosis by binding to the IRES domain in the 5' UTR of PIK3CB and CTSZ and inhibiting their translation. Our findings suggest that PDCD4 plays an important role in MM development by regulating the expression of PIK3CB, CTSZ, and XIAP, and highlight new potential molecular targets for MM treatment., (© 2024 Federation of American Societies for Experimental Biology.)
- Published
- 2024
- Full Text
- View/download PDF
11. Complex interplay between RAS GTPases and RASSF effectors regulates subcellular localization of YAP.
- Author
-
Singh S, Bernal Astrain G, Hincapie AM, Goudreault M, and Smith MJ
- Subjects
- Humans, Transcription Factors metabolism, Transcription Factors genetics, YAP-Signaling Proteins metabolism, Signal Transduction, Tumor Suppressor Proteins metabolism, Tumor Suppressor Proteins genetics, Mitochondria metabolism, HEK293 Cells, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Protein Transport, Cell Membrane metabolism, ras Proteins metabolism, Adaptor Proteins, Signal Transducing metabolism, Adaptor Proteins, Signal Transducing genetics, Protein Binding
- Abstract
RAS GTPases bind effectors to convert upstream cues to changes in cellular function. Effectors of classical H/K/NRAS are defined by RBD/RA domains which recognize the GTP-bound conformation of these GTPases, yet the specificity of RBD/RAs for over 160 RAS superfamily proteins remains poorly explored. We have systematically mapped interactions between BRAF and four RASSF effectors, the largest family of RA-containing proteins, with all RAS, RHO and ARF small GTPases. 39 validated complexes reveal plasticity in RASSF binding, while BRAF demonstrates tight specificity for classical H/K/NRAS. Complex between RASSF5 and diverse RAS GTPases at the plasma membrane can activate Hippo signalling and sequester YAP in the cytosol. RASSF8 undergoes liquid-liquid phase separation and resides in YAP-associated membraneless condensates, which also engage several RAS and RHO GTPases. The poorly studied RASSF3 has been identified as a first potential effector of mitochondrial MIRO proteins, and its co-expression with these GTPases impacts mitochondria and peroxisome distribution. These data reveal the complex nature of GTPase-effector interactions and show their systematic elucidation can reveal completely novel and biologically relevant cellular processes., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
12. Mild Therapeutic Hypothermia Alleviated Myocardial Ischemia/Reperfusion Injury via Targeting SLC25A10 to Suppress Mitochondrial Apoptosis.
- Author
-
Ma S, Song Y, Xu Y, Wang C, Yang Y, Zheng Y, Lu Q, Chen Q, Wu J, Wang B, and Chen M
- Subjects
- Animals, Male, Signal Transduction, Myocardial Infarction metabolism, Myocardial Infarction pathology, Myocardial Infarction genetics, Myocardial Infarction therapy, Cells, Cultured, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Rats, Myocardial Reperfusion Injury prevention & control, Myocardial Reperfusion Injury metabolism, Myocardial Reperfusion Injury pathology, Myocardial Reperfusion Injury genetics, Apoptosis, Mitochondria, Heart metabolism, Mitochondria, Heart pathology, Mitochondria, Heart drug effects, Myocytes, Cardiac metabolism, Myocytes, Cardiac pathology, Myocytes, Cardiac drug effects, Disease Models, Animal, Hypothermia, Induced, Rats, Sprague-Dawley
- Abstract
Myocardial ischemia/reperfusion injury (MI/RI) is identified as a severe vascular emergency, and the treatment strategy of MI/RI still needs further improvement. The present study aimed to investigate the potential effects of mild therapeutic hypothermia (MTH) on MI/RI and underlying mechanisms. In ischemia/reperfusion (I/R) rats, MTH treatment significantly improved myocardial injury, attenuated myocardial infarction, and inhibited the mitochondrial apoptosis pathway. The results of proteomics identified SLC25A10 as the main target of MTH treatment. Consistently, SLC25A10 expressions in I/R rat myocardium and hypoxia and reoxygenation (H/R) cardiomyocytes were significantly suppressed, which was effectively reversed by MTH treatment. In H/R cardiomyocytes, MTH treatment significantly improved cell injury, mitochondrial dysfunction, and inhibited the mitochondrial apoptosis pathway, which were partially reversed by SLC25A10 deletion. These findings suggested that MTH treatment could protect against MI/RI by modulating SLC25A10 expression to suppress mitochondrial apoptosis pathway, providing new theoretical basis for clinical application of MTH treatment for MI/RI., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
13. Sex Differences in Dystonia.
- Author
-
Kilic-Berkmen G, Scorr LM, McKay L, Thayani M, Donsante Y, Perlmutter JS, Norris SA, Wright L, Klein C, Feuerstein JS, Mahajan A, Wagle-Shukla A, Malaty I, LeDoux MS, Pirio-Richardson S, Pantelyat A, Moukheiber E, Frank S, Ondo W, Saunders-Pullman R, Lohman K, Hess EJ, and Jinnah HA
- Subjects
- Humans, Female, Male, Adult, Middle Aged, Sex Characteristics, Dystonic Disorders genetics, Dystonic Disorders physiopathology, Dystonic Disorders epidemiology, Young Adult, Anoctamins genetics, Aged, Adolescent, Apoptosis Regulatory Proteins genetics, Sex Factors, Nuclear Proteins genetics, Child, DNA-Binding Proteins, Molecular Chaperones, Dystonia genetics
- Abstract
Background: Prior studies have indicated that female individuals outnumber male individuals for certain types of dystonia. Few studies have addressed factors impacting these sex differences or their potential biological mechanisms., Objectives: To evaluate factors underlying sex differences in the dystonias and explore potential mechanisms for these differences., Methods: Data from individuals with various types of dystonia were analyzed in relation to sex. Data came from two different sources. One source was the Dystonia Coalition database, which contains predominantly idiopathic adult-onset focal and segmental dystonias. The second source was the MDSGene database, which contains predominantly early-onset monogenic dystonias., Results: The 3222 individuals from the Dystonia Coalition included 71% female participants and 29% male participants for an overall female-to-male ratio (F:M) of 2.4. This ratio varied according to body region affected and whether dystonia was task-specific. The female predominance was age-dependent. Sex did not have a significant impact on co-existing tremor, geste antagoniste, depression or anxiety. In the 1377 individuals from the MDSGene database, female participants outnumbered male participants for some genes (GNAL, GCH1, and ANO3) but not for other genes (THAP1, TH, and TOR1A)., Conclusions: These results are in keeping with prior studies that have indicated female individuals outnumber male individuals for both adult-onset idiopathic and early onset monogenic dystonias. These results extend prior observations by revealing that sex ratios depend on the type of dystonia, age, and underlying genetics., (© 2024 International Parkinson and Movement Disorder Society.)
- Published
- 2024
- Full Text
- View/download PDF
14. NLRP1 inflammasome promotes senescence and senescence-associated secretory phenotype.
- Author
-
Muela-Zarzuela I, Suarez-Rivero JM, Gallardo-Orihuela A, Wang C, Izawa K, de Gregorio-Procopio M, Couillin I, Ryffel B, Kitaura J, Sanz A, von Zglinicki T, Mbalaviele G, and Cordero MD
- Subjects
- Animals, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, NLR Proteins metabolism, NLR Proteins genetics, Nucleotidyltransferases metabolism, Nucleotidyltransferases genetics, Mice, Tumor Suppressor Protein p53 metabolism, Tumor Suppressor Protein p53 genetics, Cells, Cultured, Mice, Knockout, Humans, NLR Family, Pyrin Domain-Containing 3 Protein, Gasdermins, Inflammasomes metabolism, Cellular Senescence, Phosphate-Binding Proteins metabolism, Phosphate-Binding Proteins genetics, Intracellular Signaling Peptides and Proteins metabolism, Intracellular Signaling Peptides and Proteins genetics, Adaptor Proteins, Signal Transducing metabolism, Adaptor Proteins, Signal Transducing genetics, Mice, Inbred C57BL, Senescence-Associated Secretory Phenotype, DNA Damage, Fibroblasts metabolism
- Abstract
Background: Senescence is a cellular aging-related process triggered by different stresses and characterized by the secretion of various inflammatory factors referred to as senescence-associated secretory phenotype (SASP), some of which are produced by the NLRP3 inflammasome. Here, we present evidence that the NLRP1 inflammasome is a DNA damage sensor and a key mediator of senescence., Methods: Senescence was induced in fibroblasts in vitro and in mice. Cellular senescence was assessed by Western blot analysis of several proteins, including p16, p21, p53, and SASP factors, released in the culture media or serum. Inflammasome components, including NLRP1, NLRP3 and GSDMD were knocked out or silenced using siRNAs., Results: In vitro and in vivo results suggest that the NLRP1 inflammasome promotes senescence by regulating the expression of p16, p21, p53, and SASP factors in a Gasdermin D (GSDMD)-dependent manner. Mechanistically, the NLRP1 inflammasome is activated in response to genomic damage detected by the cytosolic DNA sensor cGMP-AMP (cGAMP) synthase (cGAS)., Conclusion: Our findings show that NLRP1 is a cGAS-dependent DNA damage sensor during senescence and a mediator of SASP release through GSDMD. This study advances the knowledge on the biology of the NLRP1 inflammasome and highlights this pathway as a potential pharmcological target to modulate senescence., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
15. FAF1 Gene Involvement in Pituitary Corticotroph Tumors.
- Author
-
Nguyen M, Maria AG, Faucz FR, Trivellin G, Stratakis CA, and Tatsi C
- Subjects
- Animals, Humans, Male, Mice, Female, Pituitary ACTH Hypersecretion genetics, Pituitary ACTH Hypersecretion pathology, Pituitary ACTH Hypersecretion metabolism, Adult, Middle Aged, Pituitary Neoplasms genetics, Pituitary Neoplasms pathology, Pituitary Neoplasms metabolism, ACTH-Secreting Pituitary Adenoma genetics, ACTH-Secreting Pituitary Adenoma pathology, ACTH-Secreting Pituitary Adenoma metabolism, Adrenocorticotropic Hormone metabolism, Adaptor Proteins, Signal Transducing genetics, Adaptor Proteins, Signal Transducing metabolism, Apoptosis Regulatory Proteins genetics, Apoptosis Regulatory Proteins metabolism, Mice, Knockout
- Abstract
Cushing's disease (CD) is caused by rare pituitary corticotroph tumors that lead to corticotropin (ACTH) excess. Variants in FAF1 , a pro-apoptotic protein involved in FAS-induced cell death, have been implicated in malignant disorders but the involvement of FAF1 in pituitary tumors has not been studied. Genetic data from patients with CD were reviewed for variants in FAF1 gene. Knockout mice (KO) were followed to assess the development of any pituitary disorder or cortisol excess. AtT-20 cells were used to study the effects of the variants of interest on ACTH secretion and cell proliferation. Three variants of interest were identified in 5 unique patients, two of which had rare allele frequency in genomic databases and were predicted to be likely pathogenic. KO mice were followed over time and no difference in their length/weight was noted. Additionally, KO mice did not develop any pituitary lesions and retained similar corticosterone secretion with wild type. AtT-20 cells transfected with FAF1 variants of interest or WT expression plasmids showed no significant difference in cell death or Pomc gene expression. However, in silico prediction models suggested significant differences in secondary structures of the produced proteins. In conclusion, we identified two FAF1 variants in patients diagnosed with CD with a potential pathogenic effect on the protein function and structure. Our in vitro and in vivo studies did not reveal an association of FAF1 defects with pituitary tumorigenesis and further studies may be needed to understand any association., Competing Interests: CAS, FRF, and GT hold a patent on GPR101 and its function (US Patent No. 10,350,273, Treatment of Hormonal Disorders of Growth). CAS also holds patents on the function of the PRKAR1A and PDE11A genes and related issues; his laboratory had received research funding on the GPR101 gene, and on abnormal growth hormone secretion and its treatment by Pfizer, Inc. CAS is currently employed by ELPEN, SA and has been consulting for Lundbeck Pharmaceuticals and Sync, SA. CT received research funding on treatment of abnormal growth hormone secretion by Pfizer, Inc., (Thieme. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
16. Inhibition of autophagy prevents cardiac dysfunction at early stages of cardiomyopathy in Bag3-deficient hearts.
- Author
-
Maroli G, Schänzer A, Günther S, Garcia-Gonzalez C, Rupp S, Schlierbach H, Chen Y, Graumann J, Wietelmann A, Kim J, and Braun T
- Subjects
- Animals, Mice, Myocardium metabolism, Myocardium pathology, Chloroquine pharmacology, Mice, Knockout, Autophagy, Cardiomyopathies metabolism, Cardiomyopathies pathology, Cardiomyopathies genetics, Adaptor Proteins, Signal Transducing metabolism, Adaptor Proteins, Signal Transducing genetics, Adaptor Proteins, Signal Transducing deficiency, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Apoptosis Regulatory Proteins deficiency, Myocytes, Cardiac metabolism, Myocytes, Cardiac pathology
- Abstract
The HSP70 co-chaperone BAG3 targets unfolded proteins to degradation via chaperone assisted selective autophagy (CASA), thereby playing pivotal roles in the proteostasis of adult cardiomyocytes (CMs). However, the complex functions of BAG3 for regulating autophagy in cardiac disease are not completely understood. Here, we demonstrate that conditional inactivation of Bag3 in murine CMs leads to age-dependent dysregulation of autophagy, associated with progressive cardiomyopathy. Surprisingly, Bag3-deficient CMs show increased canonical and non-canonical autophagic flux in the juvenile period when first signs of cardiac dysfunction appear, but reduced autophagy during later stages of the disease. Juvenile Bag3-deficient CMs are characterized by decreased levels of soluble proteins involved in synchronous contraction of the heart, including the gap junction protein Connexin 43 (CX43). Reiterative administration of chloroquine (CQ), an inhibitor of canonical and non-canonical autophagy, but not inactivation of Atg5, restores normal concentrations of soluble cardiac proteins in juvenile Bag3-deficient CMs without an increase of detergent-insoluble proteins, leading to complete recovery of early-stage cardiac dysfunction in Bag3-deficient mice. We conclude that loss of Bag3 in CMs leads to age-dependent differences in autophagy and cardiac dysfunction. Increased non-canonical autophagic flux in the juvenile period removes soluble proteins involved in cardiac contraction, leading to early-stage cardiomyopathy, which is prevented by reiterative CQ treatment., Competing Interests: Conflicts of interest None declared., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
17. KRIT1 in vascular biology and beyond.
- Author
-
Glading AJ
- Subjects
- Humans, Animals, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Mutation, KRIT1 Protein metabolism, KRIT1 Protein genetics, Hemangioma, Cavernous, Central Nervous System metabolism, Hemangioma, Cavernous, Central Nervous System genetics, Hemangioma, Cavernous, Central Nervous System pathology, Endothelial Cells metabolism, Endothelial Cells pathology
- Abstract
KRIT1 is a 75 kDa scaffolding protein which regulates endothelial cell phenotype by limiting the response to inflammatory stimuli and maintaining a quiescent and stable endothelial barrier. Loss-of-function mutations in KRIT1 lead to the development of cerebral cavernous malformations (CCM), a disease marked by the formation of abnormal blood vessels which exhibit a loss of barrier function, increased endothelial proliferation, and altered gene expression. While many advances have been made in our understanding of how KRIT1, and the functionally related proteins CCM2 and PDCD10, contribute to the regulation of blood vessels and the vascular barrier, some important open questions remain. In addition, KRIT1 is widely expressed and KRIT1 and the other CCM proteins have been shown to play important roles in non-endothelial cell types and tissues, which may or may not be related to their role as pathogenic originators of CCM. In this review, we discuss some of the unsettled questions regarding the role of KRIT1 in vascular physiology and discuss recent advances that suggest this ubiquitously expressed protein may have a role beyond the endothelial cell., (© 2024 The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
18. Disruption of the ZFP574-THAP12 complex suppresses B cell malignancies in mice.
- Author
-
Zhong X, Moresco JJ, SoRelle JA, Song R, Jiang Y, Nguyen MT, Wang J, Bu CH, Moresco EMY, Beutler B, and Choi JH
- Subjects
- Animals, Mice, Leukemia, B-Cell genetics, Leukemia, B-Cell pathology, Leukemia, B-Cell metabolism, DNA-Binding Proteins genetics, DNA-Binding Proteins metabolism, Apoptosis Regulatory Proteins genetics, Apoptosis Regulatory Proteins metabolism, Transcription Factors genetics, Transcription Factors metabolism, Mice, Inbred C57BL, Lymphoma, B-Cell genetics, Lymphoma, B-Cell pathology, Lymphoma, B-Cell metabolism, B-Lymphocytes metabolism
- Abstract
Despite the availability of life-extending treatments for B cell leukemias and lymphomas, many of these cancers remain incurable. Thus, the development of new molecular targets and therapeutics is needed to expand treatment options. To identify new molecular targets, we used a forward genetic screen in mice to identify genes required for development or survival of lymphocytes. Here, we describe Zfp574 , an essential gene encoding a zinc finger protein necessary for normal and malignant lymphocyte survival. We show that ZFP574 interacts with zinc finger protein THAP12 and promotes the G1-to-S-phase transition during cell cycle progression. Mutation of ZFP574 impairs nuclear localization of the ZFP574-THAP12 complex. ZFP574 or THAP12 deficiency results in cell cycle arrest and impaired lymphoproliferation. Germline mutation, acute gene deletion, or targeted degradation of ZFP574 suppressed Myc-driven B cell leukemia in mice, but normal B cells were largely spared, permitting long-term survival, whereas complete lethality was observed in control animals. Our findings support the identification of drugs targeting ZFP574-THAP12 as a unique strategy to treat B cell malignancies., Competing Interests: Competing interests statement:The authors declare no competing interest.
- Published
- 2024
- Full Text
- View/download PDF
19. DAP3 promotes mitochondrial activity and tumour progression in hepatocellular carcinoma by regulating MT-ND5 expression.
- Author
-
Tan S, Zhang X, Guo X, Pan G, Yan L, Ding Z, Li R, Wang D, Yan Y, Dong Z, and Li T
- Subjects
- Humans, Animals, Cell Line, Tumor, Cell Proliferation, Gene Expression Regulation, Neoplastic, Mice, Nude, Mice, Male, Cell Movement genetics, Mitochondrial Proteins metabolism, Mitochondrial Proteins genetics, Epithelial-Mesenchymal Transition genetics, Electron Transport Complex I metabolism, Electron Transport Complex I genetics, Phosphorylation, Female, Proto-Oncogene Proteins c-akt metabolism, Mice, Inbred BALB C, RNA-Binding Proteins, Carcinoma, Hepatocellular pathology, Carcinoma, Hepatocellular genetics, Carcinoma, Hepatocellular metabolism, Liver Neoplasms pathology, Liver Neoplasms genetics, Liver Neoplasms metabolism, Mitochondria metabolism, Disease Progression, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics
- Abstract
Cancer cells often exhibit fragmented mitochondria and dysregulated mitochondrial dynamics, but the underlying mechanism remains elusive. Here, we found that the mitochondrial protein death-associated protein 3 (DAP3) is localized to mitochondria and promotes the progression of hepatocellular carcinoma (HCC) by regulating mitochondrial function. DAP3 can promote the proliferation, migration, and invasion of HCC cells in vitro and in vivo by increasing mitochondrial respiration, inducing the epithelial-mesenchymal transition (EMT), and slowing cellular senescence. Mechanistically, DAP3 can increase mitochondrial complex I activity in HCC cells by regulating the translation and expression of MT-ND5. The phosphorylation of DAP3 at Ser185 mediated by AKT is the key event mediating the mitochondrial localization and function of DAP3 in HCC cells. In addition, the DAP3 expression in HCC samples is inversely correlated with patient survival. Our results revealed a mechanism by which DAP3 promotes mitochondrial function and HCC progression by regulating MT-ND5 translation and expression, indicating that DAP3 may be a therapeutic target for HCC., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
20. The splicing factor CCAR1 regulates the Fanconi anemia/BRCA pathway.
- Author
-
Harada N, Asada S, Jiang L, Nguyen H, Moreau L, Marina RJ, Adelman K, Iyer DR, and D'Andrea AD
- Subjects
- Humans, BRCA1 Protein metabolism, BRCA1 Protein genetics, BRCA2 Protein metabolism, BRCA2 Protein genetics, DNA Repair, Endodeoxyribonucleases, Exons, HEK293 Cells, HeLa Cells, Protein Binding, RNA Precursors metabolism, RNA Precursors genetics, RNA, Messenger genetics, RNA, Messenger metabolism, Signal Transduction, Spliceosomes metabolism, Spliceosomes genetics, Fanconi Anemia genetics, Fanconi Anemia metabolism, Fanconi Anemia Complementation Group A Protein genetics, Fanconi Anemia Complementation Group A Protein metabolism, RNA Splicing, Splicing Factor U2AF metabolism, Splicing Factor U2AF genetics, Cell Cycle Proteins genetics, Cell Cycle Proteins metabolism, Apoptosis Regulatory Proteins genetics, Apoptosis Regulatory Proteins metabolism
- Abstract
The twenty-three Fanconi anemia (FA) proteins cooperate in the FA/BRCA pathway to repair DNA interstrand cross-links (ICLs). The cell division cycle and apoptosis regulator 1 (CCAR1) protein is also a regulator of ICL repair, though its possible function in the FA/BRCA pathway remains unknown. Here, we demonstrate that CCAR1 plays a unique upstream role in the FA/BRCA pathway and is required for FANCA protein expression in human cells. Interestingly, CCAR1 co-immunoprecipitates with FANCA pre-mRNA and is required for FANCA mRNA processing. Loss of CCAR1 results in retention of a poison exon in the FANCA transcript, thereby leading to reduced FANCA protein expression. A unique domain of CCAR1, the EF hand domain, is required for interaction with the U2AF heterodimer of the spliceosome and for excision of the poison exon. Taken together, CCAR1 is a splicing modulator required for normal splicing of the FANCA mRNA and other mRNAs involved in various cellular pathways., Competing Interests: Declaration of interests A.D.D. reports consulting for AbbVie, Deerfield Management Company, Impact Therapeutics, Moderna Therapeutics, PrimeFour Therapeutics, Schrödinger Inc., Servier BioInnovation LLC, and Tango Therapeutics; is a Scientific Advisory Board Member and Stockholder for Impact Therapeutics and Covant Therapeutics. K.A. is a member of the Advisory Board of Molecular Cell, the SAB of CAMP4 Therapeutics, consults for Syros Pharmaceuticals and Odyssey Therapeutics, and received research funding from Novartis not related to this work., (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
21. NLRC5 senses NAD + depletion, forming a PANoptosome and driving PANoptosis and inflammation.
- Author
-
Sundaram B, Pandian N, Kim HJ, Abdelaal HM, Mall R, Indari O, Sarkar R, Tweedell RE, Alonzo EQ, Klein J, Pruett-Miller SM, Vogel P, and Kanneganti TD
- Subjects
- Animals, Mice, Humans, Immunity, Innate, Mice, Inbred C57BL, Reactive Oxygen Species metabolism, Mice, Knockout, Signal Transduction, HEK293 Cells, Inflammasomes metabolism, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Toll-Like Receptors metabolism, Male, Cytokines metabolism, Calcium-Binding Proteins, Inflammation metabolism, Intracellular Signaling Peptides and Proteins metabolism, Intracellular Signaling Peptides and Proteins genetics, NAD metabolism
- Abstract
NLRs constitute a large, highly conserved family of cytosolic pattern recognition receptors that are central to health and disease, making them key therapeutic targets. NLRC5 is an enigmatic NLR with mutations associated with inflammatory and infectious diseases, but little is known about its function as an innate immune sensor and cell death regulator. Therefore, we screened for NLRC5's role in response to infections, PAMPs, DAMPs, and cytokines. We identified that NLRC5 acts as an innate immune sensor to drive inflammatory cell death, PANoptosis, in response to specific ligands, including PAMP/heme and heme/cytokine combinations. NLRC5 interacted with NLRP12 and PANoptosome components to form a cell death complex, suggesting an NLR network forms similar to those in plants. Mechanistically, TLR signaling and NAD
+ levels regulated NLRC5 expression and ROS production to control cell death. Furthermore, NLRC5-deficient mice were protected in hemolytic and inflammatory models, suggesting that NLRC5 could be a potential therapeutic target., Competing Interests: Declaration of interests St. Jude Children’s Research Hospital filed a provisional patent application on methods for modulating NLRP12 and NLRC5 described in this study, listing B.S. and T.-D.K. as inventors (serial no. 63/501,430). The PCT application was published with the World Intellectual Property Organization (WO 2024/097571 A1)., (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
22. Acupuncture Therapy Modulating "Du" Channel Attenuates Ischemic Stroke-induced Disorders by Modulating REST-mediated miR-21/PDCD4 Signaling Transduction.
- Author
-
Lei G, Wu X, Zhang S, Tong X, and Zhou G
- Subjects
- Animals, Male, Rats, Apoptosis, Brain metabolism, Ischemic Stroke metabolism, Ischemic Stroke therapy, Ischemic Stroke genetics, Rats, Sprague-Dawley, Repressor Proteins, RNA-Binding Proteins metabolism, RNA-Binding Proteins genetics, Acupuncture Therapy methods, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Infarction, Middle Cerebral Artery therapy, Infarction, Middle Cerebral Artery metabolism, MicroRNAs genetics, MicroRNAs metabolism, Signal Transduction
- Abstract
Acupuncture is a traditional Chinese therapy with treating potential against cognitive dysfunction. MicroRNA-21-3p (miR-21-3p) is well characterized for its benefits on neural tissues. The current study hypothesizes that the acupuncture aiming "Du" channel could attenuate IS-induced neural disorders by modulating the function of REST/miR-21-3p axis. Complications associated with IS are induced by a middle cerebral artery occlusion (MCAO) model in vivo. The disorders are then handled with the acupuncture with nimodipine as the positive control. It is found that the acupuncture improved cognitive function, reduced brain apoptosis, and increased the viable neuron number of model rats. Additionally, the production of cytokines is also suppressed by the acupuncture. At the molecular level, the level of miR-21-3p was up-regulated, while the level of REST was down-regulated by the acupuncture. The changes in miR-REST/21-3p contributed to the inhibition of PDCD4. Collectively, the findings in the current study highlight that miR-21-3p is associated with the anti-IS function of the acupuncture, which is mediated by the inhibition of REST., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
23. Circ_BBS9 as an early diagnostic biomarker for lung adenocarcinoma: direct interaction with IFIT3 in the modulation of tumor immune microenvironment.
- Author
-
Peng D, Liang M, Li L, Yang H, Fang D, Chen L, and Guan B
- Subjects
- Humans, Animals, Mice, Cell Line, Tumor, MicroRNAs genetics, Male, Cell Proliferation, Female, Apoptosis Regulatory Proteins genetics, Apoptosis Regulatory Proteins metabolism, RNA-Binding Proteins genetics, RNA-Binding Proteins metabolism, Middle Aged, Mice, Nude, Intracellular Signaling Peptides and Proteins, Tumor Microenvironment immunology, Tumor Microenvironment genetics, RNA, Circular genetics, Adenocarcinoma of Lung immunology, Adenocarcinoma of Lung genetics, Adenocarcinoma of Lung diagnosis, Lung Neoplasms immunology, Lung Neoplasms genetics, Lung Neoplasms diagnosis, Biomarkers, Tumor genetics, Gene Expression Regulation, Neoplastic, Ferroptosis genetics, Ferroptosis immunology
- Abstract
Background: Introduction: Circular RNAs (circRNAs) have been identified as significant contributors to the development and advancement of cancer. The objective of this study was to examine the expression and clinical implications of circRNA circ_BBS9 in lung adenocarcinoma (LUAD), as well as its potential modes of action., Methods: The expression of Circ_BBS9 was examined in tissues and cell lines of LUAD through the utilization of microarray profiling, quantitative real-time polymerase chain reaction (qRT-PCR), and western blot analysis. In this study, we assessed the impact of circ_BBS9 on the proliferation of LUAD cells, as well as its influence on ferroptosis and tumor formation. To analyze these effects, we employed CCK-8 assays and ferroptosis assays. The identification of proteins that interact with Circ_BBS9 was achieved through the utilization of RNA pull-down and mass spectrometry techniques. A putative regulatory network comprising circ_BBS9, miR-7150, and IFIT3 was established using bioinformatics study. The investigation also encompassed the examination of the correlation between the expression of IFIT3 and the invasion of immune cells., Results: Circ_BBS9 was significantly downregulated in LUAD tissues and cell lines. Low circ_BBS9 expression correlated with poor prognosis. Functional experiments showed that circ_BBS9 overexpression inhibited LUAD cell proliferation and promoted ferroptosis in vitro and suppressed tumor growth in vivo . Mechanistically, circ_BBS9 was found to directly interact with IFIT3 and regulate its expression by acting as a sponge for miR-7150. Additionally, IFIT3 expression correlated positively with immune infiltration in LUAD., Conclusion: Circ_BBS9 has been identified as a tumor suppressor in lung adenocarcinoma (LUAD) and holds promise as a diagnostic biomarker. The potential mechanism of action involves the modulation of ferroptosis and the immunological microenvironment through direct interaction with IFIT3 and competitive binding to miR-7150. The aforementioned findings offer new perspectives on the pathophysiology of LUAD and highlight circ_BBS9 as a potentially valuable target for therapeutic interventions., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Peng, Liang, Li, Yang, Fang, Chen and Guan.)
- Published
- 2024
- Full Text
- View/download PDF
24. Relationship between the Cell Death-Inducing DNA Fragmentation Factor 45-Like Effector Protein Family and the Risk of Dyslipidemia.
- Author
-
Song J, Kang H, and Cheng Y
- Subjects
- Humans, Animals, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Lipid Droplets metabolism, Adipocytes metabolism, Obesity metabolism, Obesity genetics, Dyslipidemias metabolism, Dyslipidemias genetics, Lipid Metabolism
- Abstract
According to the research, obesity is associated with hyperlipidemia, hypertension, and type 2 diabetes mellitus, which are grouped as metabolic syndrome. Notably, under the obese status, the adipocyte could accumulate excessive lipid as lipid droplets (LDs), leading the dysfunctional fat mass. Recently, emerging evidence has shown that the cell death-inducing DNA fragmentation factor 45-like effector protein (CIDE) family played an important role in regulating lipid metabolism. In addition, diverse CIDE proteins were also confirmed to influence the intracellular lipid metabolism, such as within adipocyte, hepatocyte, and macrophage. Nevertheless, the results which showed the regulatory influence of CIDE proteins are significantly contradictory from in vitro experiments and in vivo clinical studies. Similarly, recent studies have changed the perception of these proteins, redefining them as regulators of lipid droplet dynamics and fat metabolism, which contribute to a healthy metabolic phenotype in humans. However, the underlying mechanisms by which the diverse CIDE proteins alter lipid metabolism are not elucidated. In the current review, the understandings of CIDE proteins in lipid catabolism were well-summarized. On the other hand, the relatively mechanisms were also proposed for the further understandings of the CIDE protein family., Competing Interests: The authors declare no conflict of interest., (© 2024 The Author(s). Published by IMR Press.)
- Published
- 2024
- Full Text
- View/download PDF
25. The Regulatory Impact of CFLAR Methylation Modification on Liver Lipid Metabolism.
- Author
-
Ye C, Jiang W, Hu T, Liang J, and Chen Y
- Subjects
- Animals, Humans, Male, Mice, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Diet, High-Fat adverse effects, Methylation, Mice, Inbred C57BL, Hepatocytes metabolism, Lipid Metabolism, Liver metabolism, Non-alcoholic Fatty Liver Disease metabolism, Non-alcoholic Fatty Liver Disease genetics, Protein-Arginine N-Methyltransferases metabolism, Protein-Arginine N-Methyltransferases genetics
- Abstract
Non-alcoholic fatty liver disease (NAFLD) has emerged as the leading cause of chronic liver disease worldwide. Caspase 8 and FADD-like apoptosis regulator (CFLAR) has been identified as a potent factor in mitigating non-alcoholic steatohepatitis (NASH) by inhibiting the N-terminal dimerization of apoptosis signal-regulating kinase 1 (ASK1). While arginine methyltransferase 1 (PRMT1) was previously reported to be associated with increased hepatic glucose production, its involvement in hepatic lipid metabolism remains largely unexplored. The interaction between PRMT1 and CFLAR and the methylation of CFLAR were verified by Co-IP and immunoblotting assays. Recombinant adenoviruses were generated for overexpression or knockdown of PRMT1 in hepatocytes. The role of PRMT1 in NAFLD was investigated in normal and high-fat diet-induced obese mice. In this study, we found a significant upregulation of PRMT1 and downregulation of CFLAR after 48h of fasting, while the latter significantly rebounded after 12h of refeeding. The expression of PRMT1 increased in the livers of mice fed a methionine choline-deficient (MCD) diet and in hepatocytes challenged with oleic acid (OA)/palmitic acid (PA). Overexpression of PRMT1 not only inhibited the expression of genes involved in fatty acid oxidation (FAO) and promoted the expression of genes involved in fatty acid synthesis (FAS), resulting in increased triglyceride accumulation in primary hepatocytes, but also enhanced the gluconeogenesis of primary hepatocytes. Conversely, knockdown of hepatic PRMT1 significantly alleviated MCD diet-induced hepatic lipid metabolism abnormalities and liver injury in vivo, possibly through the upregulation of CFLAR protein levels. Knockdown of PRMT1 suppressed the expression of genes related to FAS and enhanced the expression of genes involved in FAO, causing decreased triglyceride accumulation in OA/PA-treated primary hepatocytes in vitro. Although short-term overexpression of PRMT1 had no significant effect on hepatic triglyceride levels under physiological conditions, it resulted in increased serum triglyceride and fasting blood glucose levels in normal C57BL/6J mice. More importantly, PRMT1 was observed to interact with and methylate CFLAR, ultimately leading to its ubiquitination-mediated protein degradation. This process subsequently triggered the activation of c-Jun N-terminal kinase 1 (JNK1) and lipid deposition in primary hepatocytes. Together, these results suggested that PRMT1-mediated methylation of CFLAR plays a critical role in hepatic lipid metabolism. Targeting PRMT1 for drug design may represent a promising strategy for the treatment of NAFLD.
- Published
- 2024
- Full Text
- View/download PDF
26. NLRP3, NLRP6, and NLRP12 are inflammasomes with distinct expression patterns.
- Author
-
Wei B, Billman ZP, Nozaki K, Goodridge HS, and Miao EA
- Subjects
- Humans, Animals, HEK293 Cells, Inflammasomes metabolism, NLR Family, Pyrin Domain-Containing 3 Protein metabolism, NLR Family, Pyrin Domain-Containing 3 Protein genetics, Apoptosis Regulatory Proteins genetics, Apoptosis Regulatory Proteins metabolism, Intracellular Signaling Peptides and Proteins genetics, Intracellular Signaling Peptides and Proteins metabolism
- Abstract
Inflammasomes are sensors that detect cytosolic microbial molecules or cellular damage, and in response they initiate a form of lytic regulated cell death called pyroptosis. Inflammasomes signal via homotypic protein-protein interactions where CARD or PYD domains are crucial for recruiting downstream partners. Here, we screened these domains from NLR family proteins, and found that the PYD domain of NLRP6 and NLRP12 could activate caspase-1 to induce cleavage of IL-1β and GSDMD. Inflammasome reconstitution verified that full length NLRP6 and NLRP12 formed inflammasomes in vitro , and NLRP6 was more prone to auto-activation. NLRP6 was highly expressed in intestinal epithelial cells (IEC), but not in immune cells. Molecular phylogeny analysis found that NLRP12 was closely related to NLRP3, but the activation mechanisms are different. NLRP3 was highly expressed in monocytes and macrophages, and was modestly but appreciably expressed in neutrophils. In contrast, NLRP12 was specifically expressed in neutrophils and eosinophils, but was not detectable in macrophages. NLRP12 mutations cause a periodic fever syndrome called NLRP12 autoinflammatory disease. We found that several of these patient mutations caused spontaneous activation of caspase-1 in vitro , which likely causes their autoinflammatory disease. Different cell types have unique cellular physiology and structures which could be perturbed by a pathogen, necessitating expression of distinct inflammasome sensors to monitor for signs of infection., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Wei, Billman, Nozaki, Goodridge and Miao.)
- Published
- 2024
- Full Text
- View/download PDF
27. Specific and efficient knockdown of intracellular miRNA using partially neutralized phosphate-methylated DNA oligonucleic acid-loaded mesoporous silica nanoparticles.
- Author
-
Sung YJ, Cai WT, Chen YP, Chan HW, Lin CK, Wang PH, and Chen WY
- Subjects
- Humans, Porosity, HCT116 Cells, Phosphates chemistry, Particle Size, Oligonucleotides, Antisense chemistry, Oligonucleotides, Antisense pharmacology, PTEN Phosphohydrolase metabolism, PTEN Phosphohydrolase genetics, Surface Properties, RNA-Binding Proteins metabolism, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Silicon Dioxide chemistry, MicroRNAs genetics, MicroRNAs metabolism, Nanoparticles chemistry, DNA chemistry
- Abstract
Antisense oligonucleotides (ASOs) are molecules used to regulate RNA expression by targeting specific RNA sequences. One specific type of ASO, known as neutralized DNA (nDNA), contains site-specific methyl phosphotriester (MPTE) linkages on the phosphate backbone, changing the negatively charged DNA phosphodiester into a neutralized MPTE with designed locations. While nDNA has previously been employed as a sensitive nucleotide sequencing probe for the PCR, the potential of nDNA in intracellular RNA regulation and gene therapy remains underexplored. Our study aims to evaluate the regulatory capacity of nDNA as an ASO probe in cellular gene expression. We demonstrated that by tuning MPTE locations, partially and intermediately methylated nDNA loaded onto mesoporous silica nanoparticles (MSNs) can effectively knock down the intracellular miRNA, subsequently resulting in downstream mRNA regulation in colorectal cancer cell HCT116. Additionally, the nDNA ASO-loaded MSNs exhibit superior efficacy in reducing miR-21 levels over 72 hours compared to the efficacy of canonical DNA ASO-loaded MSNs. The reduction in the miR-21 level subsequently resulted in the enhanced mRNA levels of tumour-suppressing genes PTEN and PDCD4. Our findings underscore the potential of nDNA in gene therapies, especially in cancer treatment via a fine-tuned methylation location.
- Published
- 2024
- Full Text
- View/download PDF
28. YIPF3 and YIPF4 regulate autophagic turnover of the Golgi apparatus.
- Author
-
Kitta S, Kaminishi T, Higashi M, Shima T, Nishino K, Nakamura N, Kosako H, Yoshimori T, and Kuma A
- Subjects
- Humans, HeLa Cells, Membrane Proteins metabolism, Membrane Proteins genetics, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Proteomics methods, Membrane Transport Proteins metabolism, Membrane Transport Proteins genetics, Golgi Apparatus metabolism, Autophagy, Microtubule-Associated Proteins metabolism, Microtubule-Associated Proteins genetics, Adaptor Proteins, Signal Transducing metabolism, Adaptor Proteins, Signal Transducing genetics
- Abstract
The degradation of organelles by autophagy is essential for cellular homeostasis. The Golgi apparatus has recently been demonstrated to be degraded by autophagy, but little is known about how the Golgi is recognized by the forming autophagosome. Using quantitative proteomic analysis and two novel Golgiphagy reporter systems, we found that the five-pass transmembrane Golgi-resident proteins YIPF3 and YIPF4 constitute a Golgiphagy receptor. The interaction of this complex with LC3B, GABARAP, and GABARAPL1 is dependent on a LIR motif within YIPF3 and putative phosphorylation sites immediately upstream; the stability of the complex is governed by YIPF4. Expression of a YIPF3 protein containing a mutated LIR motif caused an elongated Golgi morphology, indicating the importance of Golgi turnover via selective autophagy. The reporter assays reported here may be readily adapted to different experimental contexts to help deepen our understanding of Golgiphagy., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
29. Human tumor suppressor PDCD4 directly interacts with ribosomes to repress translation.
- Author
-
Ye X, Huang Z, Li Y, Wang M, Meng W, Miao M, and Cheng J
- Subjects
- Humans, Protein Binding, RNA, Messenger metabolism, RNA, Messenger genetics, RNA-Binding Proteins metabolism, RNA-Binding Proteins genetics, Ribosomes metabolism, Protein Biosynthesis, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics
- Published
- 2024
- Full Text
- View/download PDF
30. A novel C-type lectin protein (BjCTL5) interacts with apoptosis stimulating proteins of p53 (ASPP) to activate NF-κB signaling pathway in primitive chordate.
- Author
-
Fan W, Chen J, Cao Y, Tan J, Li J, Wang S, Jin P, and Song X
- Subjects
- Animals, Humans, Apoptosis, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Protein Binding, HEK293 Cells, Receptors, Pattern Recognition metabolism, Receptors, Pattern Recognition genetics, Immunity, Innate, Signal Transduction, NF-kappa B metabolism, Lancelets genetics, Lancelets immunology, Lancelets metabolism, Lectins, C-Type metabolism, Lectins, C-Type genetics, Staphylococcus aureus immunology, Staphylococcus aureus physiology
- Abstract
C-type lectin proteins (CTLs), a group of pattern recognition receptors (PRRs), play pivotal roles in immune responses. However, the signal transduction and regulation of CTLs in cephalochordates have yet to be explored. In this study, we examined the composition of CTLs in Branchiostoma japonicum, identifying a total of 272 CTLs. These CTLs underwent further analysis concerning domain arrangement, tandem and segmental duplication events. A multidomain C-type lectin gene, designated as BjCTL5, encompassing CLECT, KR, CUB, MAM, and SR domains, was the focal point of our investigation. BjCTL5 exhibits ubiquitous expression across all detected tissues and is responsive to stimulation by LPS, mannose, and poly (I:C). The recombinant protein of BjCTL5 can bind to Escherichia coli and Staphylococcus aureus, inducing their agglutination and inhibiting the proliferation of S. aureus. Yeast two-hybrid, CoIP, and confocal immunofluorescence experiments revealed the interaction between BjCTL5 and apoptosis-stimulating proteins of p53, BjASPP. Intriguingly, BjCTL5 was observed to induce the luciferase activity of the NF-κB promoter in HEK293T cells. These results suggested a potential interaction between BjCTL5 and BjASPP, implicating that they involve in the activation of the NF-κB signaling pathway, which provides an evolutionary viewpoint on NF-κB signaling pathway in primitive chordate., (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
31. STAT1 mediated downregulation of the tumor suppressor gene PDCD4, is driven by the atypical cadherin FAT1, in glioblastoma.
- Author
-
Khan MT, Almas M, Malik N, Jalota A, Sharma S, Ali SA, Luthra K, Suri V, Suri A, Basak S, Seth P, Chosdol K, and Sinha S
- Subjects
- Humans, Cell Line, Tumor, Promoter Regions, Genetic genetics, Cell Movement, Brain Neoplasms genetics, Brain Neoplasms metabolism, Brain Neoplasms pathology, Glioblastoma genetics, Glioblastoma metabolism, Glioblastoma pathology, STAT1 Transcription Factor metabolism, STAT1 Transcription Factor genetics, RNA-Binding Proteins metabolism, RNA-Binding Proteins genetics, Cadherins metabolism, Cadherins genetics, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Down-Regulation, Gene Expression Regulation, Neoplastic
- Abstract
STAT1 (Signal Transducer and Activator of Transcription 1), belongs to the STAT protein family, essential for cytokine signaling. It has been reported to have either context dependent oncogenic or tumor suppressor roles in different tumors. Earlier, we demonstrated that Glioblastoma multiforme (GBMs) overexpressing FAT1, an atypical cadherin, had poorer outcomes. Overexpressed FAT1 promotes pro-tumorigenic inflammation, migration/invasion by downregulating tumor suppressor gene, PDCD4. Here, we demonstrate that STAT1 is a novel mediator downstream to FAT1, in downregulating PDCD4 in GBMs. In-silico analysis of GBM databases as well as q-PCR analysis in resected GBM tumors showed positive correlation between STAT1 and FAT1 mRNA levels. Kaplan-Meier analysis showed poorer survival of GBM patients having high FAT1 and STAT1 expression. SiRNA-mediated knockdown of FAT1 decreased STAT1 and increased PDCD4 expression in glioblastoma cells (LN229 and U87MG). Knockdown of STAT1 alone resulted in increased PDCD4 expression. In silico analysis of the PDCD4 promoter revealed four putative STAT1 binding sites (Site1-Site4). ChIP assay confirmed the binding of STAT1 to site1. ChIP-PCR revealed decrease in the binding of STAT1 on the PDCD4 promoter after FAT1 knockdown. Site directed mutagenesis of Site1 resulted in increased PDCD4 luciferase activity, substantiating STAT1 mediated PDCD4 inhibition. EMSA confirmed STAT1 binding to the Site 1 sequence. STAT1 knockdown led to decreased expression of pro-inflammatory cytokines and EMT markers, and reduced migration/invasion of GBM cells. This study therefore identifies STAT1 as a novel downstream mediator of FAT1, promoting pro-tumorigenic activity in GBM, by suppressing PDCD4 expression., Competing Interests: Declaration of competing interest The authors declare no conflict of interest., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
32. TP53AIP1 induce autophagy via the AKT/mTOR signaling pathway in the breast cancer cells.
- Author
-
Liu S, Xu T, Chen X, Tang L, Li L, Zhang L, Yang Y, and Huang J
- Subjects
- Animals, Female, Humans, Mice, Cell Line, Tumor, Cell Proliferation, Epithelial-Mesenchymal Transition genetics, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Autophagy genetics, Breast Neoplasms pathology, Breast Neoplasms metabolism, Breast Neoplasms genetics, Proto-Oncogene Proteins c-akt metabolism, Signal Transduction, TOR Serine-Threonine Kinases metabolism
- Abstract
Breast cancer ranks the first in the incidence of female cancer and is the most common cancer threatening the life and health of women worldwide.Tumor protein p53-regulated apoptosis-inducing protein 1 (TP53AIP1) is a pro-apoptotic gene downstream of p53. However, the role of TP53AIP1 in BC needs to be investigated. In vitro and in vivo experiments were conducted to assess the biological functions and associated mechanisms. Several bioinformatics analyses were made, CCK8 assay, wound healing, transwell assays, colony formation assay, EDU, flow cytometry, Immunofluorescence, qRT-PCR and Western-blotting were performed. In our study, we discovered that BC samples had low levels of TP53AIP1 expression, which correlated with a lower survival rate in BC patients. When TP53AIP1 was up-regulated, it caused a decrease in cell proliferation, migration, and invasion. It also induced epithelial-to-mesenchymal transition (EMT) and protective autophagy. Furthermore, the over-expression of TP53AIP1 suppressed tumor growth when tested in vivo. We also noticed that TP53AIP1 up-regulation resulted in decreased levels of phosphorylation in AKT and mTOR, suggesting a mechanistic role. In addition, we performed functional rescue experiments where the activation of AKT was able to counteract the impact of TP53AIP1 on the survival and autophagy in breast cancer cell lines. This suggests that TP53AIP1 acts as an oncogene by controlling the AKT/mTOR pathway. These findings reveal TP53AIP1 as a gene that suppresses tumor growth and triggers autophagy through the AKT/mTOR pathway in breast cancer cells. As a result, TP53AIP1 presents itself as a potential target for novel therapeutic approaches in treating breast cancer.
- Published
- 2024
- Full Text
- View/download PDF
33. HSPB8-BAG3 chaperone complex modulates cell invasion in intrahepatic cholangiocarcinoma by regulating CASA-mediated Filamin A degradation.
- Author
-
Shu B, Wen Y, Lin R, He C, Luo C, and Li F
- Subjects
- Humans, Animals, Mice, Heat-Shock Proteins metabolism, Heat-Shock Proteins genetics, Cell Movement, Cell Line, Tumor, Male, Female, Mice, Nude, Gene Expression Regulation, Neoplastic, Cholangiocarcinoma pathology, Cholangiocarcinoma metabolism, Cholangiocarcinoma genetics, Filamins metabolism, Filamins genetics, Molecular Chaperones metabolism, Molecular Chaperones genetics, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Adaptor Proteins, Signal Transducing metabolism, Adaptor Proteins, Signal Transducing genetics, Bile Duct Neoplasms pathology, Bile Duct Neoplasms metabolism, Bile Duct Neoplasms genetics, Neoplasm Invasiveness
- Abstract
The incidence of intrahepatic cholangiocarcinoma (ICC) is steadily rising, and it is associated with a high mortality rate. Clinical samples were collected to detect the expression of HSPB8 and BAG3 in ICC tissues. ICC cells were cultured and transfected with plasmids that overexpressed or silenced specific genes to investigate the impact of gene expression alterations on cell function. qPCR and Western blot techniques were utilized to measure gene and protein expression levels. A wound healing assay was conducted to assess cell migration ability. The Transwell assay was used to assess cell invasion ability. Co-IP was used to verify the binding relationship between HSPB8 and BAG3. The effects of HSPB8 and BAG3 on lung metastasis of tumors in vivo were verified by constructing a metastatic tumor model. Through the above experiments, we discovered that the expressions of HSPB8 and BAG3 were up-regulated in ICC tissues and cells, and their expressions were positively correlated. The metastatic ability of ICC cells could be promoted or inhibited by upregulating or downregulating the expression of BAG3. Furthermore, the HSPB8-BAG3 chaperone complex resulted in the abnormal degradation of Filamin A by activating autophagy. Increased expression of Filamin A inhibits the migration and invasion of ICC cells. Overexpression of HSPB8 and BAG3 in vivo promoted the lung metastasis ability of ICC cells. The HSPB8-BAG3 chaperone complex promotes ICC cell migration and invasion by regulating CASA-mediated degradation of Filamin A, offering insights for enhancing ICC therapeutic strategies.
- Published
- 2024
- Full Text
- View/download PDF
34. Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma.
- Author
-
Gulla A, Morelli E, Johnstone M, Turi M, Samur MK, Botta C, Cifric S, Folino P, Vinaixa D, Barello F, Clericuzio C, Favasuli VK, Maisano D, Talluri S, Prabhala R, Bianchi G, Fulciniti M, Wen K, Kurata K, Liu J, Penailillo J, Bragoni A, Sapino A, Richardson PG, Chauhan D, Carrasco RD, Hideshima T, Munshi NC, and Anderson KC
- Subjects
- Humans, Animals, Mice, Bortezomib pharmacology, Bortezomib therapeutic use, Calreticulin metabolism, Calreticulin genetics, Immunogenic Cell Death drug effects, Antineoplastic Agents pharmacology, Antineoplastic Agents therapeutic use, Cell Line, Tumor, Autophagy drug effects, Multiple Myeloma drug therapy, Multiple Myeloma pathology, Multiple Myeloma immunology, Multiple Myeloma genetics, Adaptor Proteins, Signal Transducing genetics, Adaptor Proteins, Signal Transducing metabolism, Drug Resistance, Neoplasm, Apoptosis Regulatory Proteins genetics, Apoptosis Regulatory Proteins metabolism, Microtubule-Associated Proteins genetics, Microtubule-Associated Proteins metabolism
- Abstract
Abstract: Immunogenic cell death (ICD) is a form of cell death by which cancer treatments can induce a clinically relevant antitumor immune response in a broad range of cancers. In multiple myeloma (MM), the proteasome inhibitor bortezomib is an ICD inducer and creates durable therapeutic responses in patients. However, eventual relapse and resistance to bortezomib appear inevitable. Here, by integrating patient transcriptomic data with an analysis of calreticulin (CRT) protein interactors, we found that GABA type A receptor-associated protein (GABARAP) is a key player whose loss prevented tumor cell death from being perceived as immunogenic after bortezomib treatment. GABARAP is located on chromosome 17p, which is commonly deleted in patients with high risk MM. GABARAP deletion impaired the exposure of the eat-me signal CRT on the surface of dying MM cells in vitro and in vivo, thus reducing tumor cell phagocytosis by dendritic cells and the subsequent antitumor T-cell response. Low GABARAP was independently associated with shorter survival in patients with MM and reduced tumor immune infiltration. Mechanistically, we found that GABARAP deletion blocked ICD signaling by decreasing autophagy and altering Golgi apparatus morphology, with consequent defects in the downstream vesicular transport of CRT. Conversely, upregulating autophagy using rapamycin restored Golgi morphology, CRT exposure, and ICD signaling in GABARAPKO cells undergoing bortezomib treatment. Therefore, coupling an ICD inducer, such as bortezomib, with an autophagy inducer, such as rapamycin, may improve patient outcomes in MM, in which low GABARAP in the form of del(17p) is common and leads to worse outcomes., (© 2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.)
- Published
- 2024
- Full Text
- View/download PDF
35. Tumor suppressor Par-4 activates autophagy-dependent ferroptosis.
- Author
-
Subburayan K, Thayyullathil F, Pallichankandy S, Cheratta AR, Alakkal A, Sultana M, Drou N, Arshad M, Palanikumar L, Magzoub M, Rangnekar VM, and Galadari S
- Subjects
- Humans, Animals, Mice, Cell Line, Tumor, Lipid Peroxidation, Iron metabolism, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Signal Transduction, Ferroptosis genetics, Autophagy, Nuclear Receptor Coactivators metabolism, Nuclear Receptor Coactivators genetics, Reactive Oxygen Species metabolism
- Abstract
Ferroptosis is a unique iron-dependent form of non-apoptotic cell death characterized by devastating lipid peroxidation. Whilst growing evidence suggests that ferroptosis is a type of autophagy-dependent cell death, the underlying molecular mechanisms regulating ferroptosis are largely unknown. In this study, through an unbiased RNA-sequencing screening, we demonstrate the activation of a multi-faceted tumor-suppressor protein Par-4/PAWR during ferroptosis. Functional studies reveal that genetic depletion of Par-4 effectively blocks ferroptosis, whereas Par-4 overexpression sensitizes cells to undergo ferroptosis. More importantly, we have determined that Par-4-triggered ferroptosis is mechanistically driven by the autophagic machinery. Upregulation of Par-4 promotes activation of ferritinophagy (autophagic degradation of ferritin) via the nuclear receptor co-activator 4 (NCOA4), resulting in excessive release of free labile iron and, hence, enhanced lipid peroxidation and ferroptosis. Inhibition of Par-4 dramatically suppresses the NCOA4-mediated ferritinophagy signaling axis. Our results also establish that Par-4 activation positively correlates with reactive oxygen species (ROS) production, which is critical for ferritinophagy-mediated ferroptosis. Furthermore, Par-4 knockdown effectively blocked ferroptosis-mediated tumor suppression in the mouse xenograft models. Collectively, these findings reveal that Par-4 has a crucial role in ferroptosis, which could be further exploited for cancer therapy., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
36. Cytoprotective Role of Autophagy in CDIP1 Expression-Induced Apoptosis in MCF-7 Breast Cancer Cells.
- Author
-
Inukai R, Mori K, Maki M, Takahara T, and Shibata H
- Subjects
- Female, Humans, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Class III Phosphatidylinositol 3-Kinases metabolism, Class III Phosphatidylinositol 3-Kinases genetics, Cytoprotection drug effects, Doxorubicin pharmacology, Gene Expression Regulation, Neoplastic drug effects, MCF-7 Cells, Apoptosis drug effects, Autophagy drug effects, Breast Neoplasms metabolism, Breast Neoplasms genetics, Breast Neoplasms pathology
- Abstract
Cell death-inducing p53-target protein 1 (CDIP1) is a proapoptotic protein that is normally expressed at low levels and is upregulated by genotoxic and endoplasmic reticulum stresses. CDIP1 has been reported to be localized to endosomes and to interact with several proteins, including B-cell receptor-associated protein 31 (BAP31) and apoptosis-linked gene 2 (ALG-2). However, the cellular and molecular mechanisms underlying CDIP1 expression-induced apoptosis remain unclear. In this study, we first demonstrated that CDIP1 was upregulated after treatment with the anticancer drug adriamycin in human breast cancer MCF-7 cells but was degraded rapidly in the lysosomal pathway. We also demonstrated that treatment with the cyclin-dependent kinase 5 (CDK5) inhibitor roscovitine led to an increase in the electrophoretic mobility of CDIP1. In addition, a phosphomimetic mutation at Ser-32 in CDIP1 resulted in an increase in CDIP1 expression-induced apoptosis. We also found that CDIP1 expression led to the induction of autophagy prior to apoptosis. Treatment of cells expressing CDIP1 with SAR405, an inhibitor of the class III phosphatidylinositol 3-kinase VPS34, caused a reduction in autophagy and promoted apoptosis. Therefore, autophagy is thought to be a defense mechanism against CDIP1 expression-induced apoptosis.
- Published
- 2024
- Full Text
- View/download PDF
37. In vivo and in vitro studies on the role of regulating Smac expression in the occurrence and development of colon cancer.
- Author
-
Zhang D and Yang N
- Subjects
- Animals, Humans, HT29 Cells, Mice, Inhibitor of Apoptosis Proteins genetics, Inhibitor of Apoptosis Proteins metabolism, Mice, Inbred BALB C, Cell Proliferation genetics, RNA, Messenger genetics, RNA, Messenger metabolism, Colonic Neoplasms genetics, Colonic Neoplasms pathology, Colonic Neoplasms metabolism, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Apoptosis genetics, Mice, Nude, Mitochondrial Proteins metabolism, Mitochondrial Proteins genetics, Intracellular Signaling Peptides and Proteins metabolism, Intracellular Signaling Peptides and Proteins genetics, Survivin metabolism, Survivin genetics, Caspase 3 metabolism, Caspase 3 genetics, Gene Expression Regulation, Neoplastic
- Abstract
We aimed to explore the role of regulating Smac expression levels in the occurrence and development of colon cancer through in vitro and in vivo experiments. Colon cancer cells HT-29 were cultured and transfected into different groups. qRT-PCR was used to detect the expression level of Smac in cells; Flow cytometry was used to detect the apoptotic ability of each group of cells; Western blot was used to detect the protein expression of Smac and apoptosis-related factors Survivin and Caspase-3; The nude mouse tumorigenesis experiment was conducted to detect the regulatory effect of regulating Smac expression levels on the growth of colon cancer transplanted tumors in vivo. In comparison to the FHC group, the HT-29 group exhibited a decrease in Smac expression. The si-Smac group, when compared with the si-NC group, showed significant reductions in Smac mRNA and protein levels, weaker cell apoptosis, increased Survivin, and decreased Caspase-3 expression. Contrarily, the oe-Smac group, against the oe-NC group, displayed increased Smac mRNA and protein levels, enhanced apoptosis, reduced Survivin, and elevated Caspase-3 expression. In nude mice tumor transplantation experiments, the LV-sh-Smac group, as opposed to the LV-sh-NC group, had tumors with greater volume and weight, reduced Smac and Caspase-3, and increased Survivin expression. In contrast, the LV-oe-Smac group, compared with the LV-oe-NC group, showed tumors with decreased volume and mass, increased expressions of Smac and Caspase-3, and decreased Survivin. Smac is lowly expressed in colon cancer. Upregulation of Smac expression can inhibit the occurrence and development of colon cancer, possibly by inhibiting Survivin expression and promoting Caspase-3 expression, thereby enhancing the pro-apoptotic function.
- Published
- 2024
- Full Text
- View/download PDF
38. Interaction of SMAC with a survivin-derived peptide alters essential cancer hallmarks: Tumor growth, inflammation, and immunosuppression.
- Author
-
Santhanam M, Kumar Pandey S, Shteinfer-Kuzmine A, Paul A, Abusiam N, Zalk R, and Shoshan-Barmatz V
- Subjects
- Humans, Animals, Mice, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins metabolism, Intracellular Signaling Peptides and Proteins genetics, Neoplasms metabolism, Neoplasms pathology, Neoplasms drug therapy, Inflammation metabolism, Xenograft Model Antitumor Assays, Protein Binding, Inhibitor of Apoptosis Proteins metabolism, Inhibitor of Apoptosis Proteins genetics, Cell-Penetrating Peptides pharmacology, Cell-Penetrating Peptides chemistry, Peptides pharmacology, Peptides chemistry, Immunosuppression Therapy, Survivin metabolism, Survivin genetics, Mitochondrial Proteins metabolism, Apoptosis, Cell Proliferation drug effects, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics
- Abstract
Second mitochondrial-derived activator of caspase (SMAC), also known as direct inhibitor of apoptosis-binding proteins with low pI (Diablo), is known as a pro-apoptotic mitochondrial protein released into the cytosol in response to apoptotic signals. We recently reported SMAC overexpression in cancers as essential for cell proliferation and tumor growth due to non-apoptotic functions, including phospholipid synthesis regulation. These functions may be associated with its interactions with partner proteins. Using a peptide array with 768 peptides derived from 11 selected SMAC-interacting proteins, we identified SMAC-interacting sequences. These SMAC-binding sequences were produced as cell-penetrating peptides targeted to the cytosol, mitochondria, or nucleus, inhibiting cell proliferation and inducing apoptosis in several cell lines. For in vivo study, a survivin/baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5)-derived peptide was selected, due to its overexpression in many cancers and its involvement in mitosis, apoptosis, autophagy, cell proliferation, inflammation, and immune responses, as a target for cancer therapy. Specifically, a SMAC-targeting survivin/BIRC5-derived peptide, given intratumorally or intravenously, strongly inhibited lung tumor growth, cell proliferation, angiogenesis, and inflammation, induced apoptosis, and remodeled the tumor microenvironment. The peptide promoted tumor infiltration of CD-8
+ cells and increased cell-intrinsic programmed cell death protein 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression, resulting in cancer cell self-destruction and increased tumor cell death, preserving immune cells. Thus, targeting the interaction between the multifunctional proteins SMAC and survivin represents an innovative therapeutic cancer paradigm., Competing Interests: Declaration of interests The authors declare that there are no competing interests., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
39. COPII with ALG2 and ESCRTs control lysosome-dependent microautophagy of ER exit sites.
- Author
-
Liao YC, Pang S, Li WP, Shtengel G, Choi H, Schaefer K, Xu CS, and Lippincott-Schwartz J
- Subjects
- Humans, Cell Cycle Proteins metabolism, Cell Cycle Proteins genetics, Protein Transport, HeLa Cells, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Autophagy physiology, TOR Serine-Threonine Kinases metabolism, Calcium metabolism, Lysosomes metabolism, Endoplasmic Reticulum metabolism, Endosomal Sorting Complexes Required for Transport metabolism, Endosomal Sorting Complexes Required for Transport genetics, Calcium-Binding Proteins metabolism, Calcium-Binding Proteins genetics, COP-Coated Vesicles metabolism, Microautophagy, Vesicular Transport Proteins metabolism, Vesicular Transport Proteins genetics
- Abstract
Endoplasmic reticulum exit sites (ERESs) are tubular outgrowths of endoplasmic reticulum that serve as the earliest station for protein sorting and export into the secretory pathway. How these structures respond to different cellular conditions remains unclear. Here, we report that ERESs undergo lysosome-dependent microautophagy when Ca
2+ is released by lysosomes in response to nutrient stressors such as mTOR inhibition or amino acid starvation in mammalian cells. Targeting and uptake of ERESs into lysosomes were observed by super-resolution live-cell imaging and focus ion beam scanning electron microscopy (FIB-SEM). The mechanism was ESCRT dependent and required ubiquitinated SEC31, ALG2, and ALIX, with a knockout of ALG2 or function-blocking mutations of ALIX preventing engulfment of ERESs by lysosomes. In vitro, reconstitution of the pathway was possible using lysosomal lipid-mimicking giant unilamellar vesicles and purified recombinant components. Together, these findings demonstrate a pathway of lysosome-dependent ERES microautophagy mediated by COPII, ALG2, and ESCRTS induced by nutrient stress., Competing Interests: Declaration of interests Portions of the technology described here are covered by US Patent 10,600,615 titled “Enhanced FIB-SEM systems for large-volume 3D imaging,” which was issued to C.S.X., K.J.H., and H.F.H. and assigned to Howard Hughes Medical Institute on 24 March 2020., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
40. The scaffold protein disabled 2 (DAB2) and its role in tumor development and progression.
- Author
-
Pandya DV, Parikh RV, Gena RM, Kothari NR, Parekh PS, Chorawala MR, Jani MA, Yadav MR, and Shah PA
- Subjects
- Humans, Animals, Epithelial-Mesenchymal Transition genetics, Disease Progression, Tumor Suppressor Proteins metabolism, Tumor Suppressor Proteins genetics, Gene Expression Regulation, Neoplastic, Cell Proliferation genetics, Carcinogenesis genetics, Carcinogenesis metabolism, Apoptosis genetics, Neoplasms genetics, Neoplasms metabolism, Neoplasms pathology, Adaptor Proteins, Signal Transducing metabolism, Adaptor Proteins, Signal Transducing genetics, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Signal Transduction
- Abstract
Background: Disabled 2 (DAB2) is a multifunctional protein that has emerged as a critical component in the regulation of tumor growth. Its dysregulation is implicated in various types of cancer, underscoring its importance in understanding the molecular mechanisms underlying tumor development and progression. This review aims to unravel the intricate molecular mechanisms by which DAB2 exerts its tumor-suppressive functions within cancer signaling pathways., Methods and Results: We conducted a comprehensive review of the literature focusing on the structure, expression, physiological functions, and tumor-suppressive roles of DAB2. We provide an overview of the structure, expression, and physiological functions of DAB2. Evidence supporting DAB2's role as a tumor suppressor is explored, highlighting its ability to inhibit cell proliferation, induce apoptosis, and modulate key signaling pathways involved in tumor suppression. The interaction between DAB2 and key oncogenes is examined, elucidating the interplay between DAB2 and oncogenic signaling pathways. We discuss the molecular mechanisms underlying DAB2-mediated tumor suppression, including its involvement in DNA damage response and repair, regulation of cell cycle progression and senescence, and modulation of epithelial-mesenchymal transition (EMT). The review explores the regulatory networks involving DAB2, covering post-translational modifications, interactions with other tumor suppressors, and integration within complex signaling networks. We also highlight the prognostic significance of DAB2 and its role in pre-clinical studies of tumor suppression., Conclusion: This review provides a comprehensive understanding of the molecular mechanisms by which DAB2 exerts its tumor-suppressive functions. It emphasizes the significance of DAB2 in cancer signaling pathways and its potential as a target for future therapeutic interventions., (© 2024. The Author(s), under exclusive licence to Springer Nature B.V.)
- Published
- 2024
- Full Text
- View/download PDF
41. Pure Parkinsonism as Possible Phenotype Expansion of THAP1-Related Disorders.
- Author
-
Ambrosini E, Cancilla R, Paul JJ, Bauer P, Garavaglia B, Barili V, Percesepe A, and Negrotti A
- Subjects
- Female, Humans, Male, Middle Aged, Phenotype, Apoptosis Regulatory Proteins genetics, DNA-Binding Proteins genetics, Nuclear Proteins genetics, Parkinsonian Disorders genetics
- Published
- 2024
- Full Text
- View/download PDF
42. Study on the role of CCM3 gene and lead exposure induced neurotoxicity through neurovascular units.
- Author
-
Li Y, Liu Y, Liu K, Tao T, Yang L, Liu R, Zhou H, Liang D, Zhang Y, Huang D, and Sun Y
- Subjects
- Humans, Female, Pregnancy, Animals, Endothelial Cells drug effects, Proto-Oncogene Proteins genetics, Mice, Cell Line, Neurotoxicity Syndromes genetics, Adult, Proteomics, Membrane Proteins, Lead toxicity, Lead blood, Apoptosis drug effects, Apoptosis Regulatory Proteins genetics, Apoptosis Regulatory Proteins metabolism
- Abstract
This study aimed to determine the toxic effects of vascular CCM3 gene deficiency and lead (Pb) exposure on the nervous system. Lentiviral transfection was performed to generate a stable strain of brain microvascular endothelial cells with low CCM3 expression. MTT assay assessed the survival rate of cells exposed to Pb, determining the dose and duration of Pb exposure in vitro. Proteomic analysis was performed on the differentially expressed proteins in bEnd3 and HT22 cells and flow cytometry was used to detect cell apoptosis. Finally, urine samples from pregnant and postpartum women were subjected to ICP-MS to detect Pb levels and HPLC to detect neurotransmitter metabolites. Based on the proteomic analysis of bEnd3 (CCM3
-/- ) cells co-cultured with HT22 cells, it was determined that HT22 cells and CCM3 genes interfered with bEnd3 cell differential proteins,2 including apoptosis and ferroptosis pathways. Electron microscopy observation, ICP-MS iron ion loading detection, and WB determination of protein GPX4 expression confirmed that HT22 cells undergo apoptosis, while bEnd3 cells undergo multiple pathways of iron death and apoptosis regulation. Furthermore, a linear regression model showed the interaction between maternal urine Pb levels, the rs9818496 site of the CCM3 SNP in peripheral blood DNA, and the concentration of the neurotransmitter metabolite 5-HIAA in maternal urine (F=4.198, P < 0.05). bEnd3 cells with CCM3 gene deficiency can induce HT22 cell apoptosis through iron death and apoptosis pathways under Pb exposure in a combined cell culture Pb exposure model, and CCM3 gene deficiency in endothelial cells and Pb exposure interacts with neural cell HT22. Epidemiological studies on maternal and newborn infants further confirmed the interaction between urine Pb levels in mothers and the SNP rs9818496 site of the CCM3 gene in peripheral blood DNA., Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Yi Sun reports financial support was provided by National Natural Science Foundation of China. Kangkang Liu reports financial support was provided by National Natural Science Foundation of China. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
43. Chronic spindle assembly checkpoint activation causes myelosuppression and gastrointestinal atrophy.
- Author
-
Karbon G, Schuler F, Braun VZ, Eichin F, Haschka M, Drach M, Sotillo R, Geley S, Spierings DC, Tijhuis AE, Foijer F, and Villunger A
- Subjects
- Animals, Mice, Atrophy, Proto-Oncogene Proteins metabolism, Proto-Oncogene Proteins genetics, Mitosis, BH3 Interacting Domain Death Agonist Protein metabolism, BH3 Interacting Domain Death Agonist Protein genetics, Cdc20 Proteins metabolism, Cdc20 Proteins genetics, Bone Marrow pathology, Bone Marrow metabolism, Membrane Proteins metabolism, Membrane Proteins genetics, Tumor Suppressor Proteins, Bcl-2-Like Protein 11 metabolism, Bcl-2-Like Protein 11 genetics, Mad2 Proteins metabolism, Mad2 Proteins genetics, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, M Phase Cell Cycle Checkpoints, Proto-Oncogene Proteins c-bcl-2 metabolism, Proto-Oncogene Proteins c-bcl-2 genetics, Apoptosis
- Abstract
Interference with microtubule dynamics in mitosis activates the spindle assembly checkpoint (SAC) to prevent chromosome segregation errors. The SAC induces mitotic arrest by inhibiting the anaphase-promoting complex (APC) via the mitotic checkpoint complex (MCC). The MCC component MAD2 neutralizes the critical APC cofactor, CDC20, preventing exit from mitosis. Extended mitotic arrest can promote mitochondrial apoptosis and caspase activation. However, the impact of mitotic cell death on tissue homeostasis in vivo is ill-defined. By conditional MAD2 overexpression, we observe that chronic SAC activation triggers bone marrow aplasia and intestinal atrophy in mice. While myelosuppression can be compensated for, gastrointestinal atrophy is detrimental. Remarkably, deletion of pro-apoptotic Bim/Bcl2l11 prevents gastrointestinal syndrome, while neither loss of Noxa/Pmaip or co-deletion of Bid and Puma/Bbc3 has such a protective effect, identifying BIM as rate-limiting apoptosis effector in mitotic cell death of the gastrointestinal epithelium. In contrast, only overexpression of anti-apoptotic BCL2, but none of the BH3-only protein deficiencies mentioned above, can mitigate myelosuppression. Our findings highlight tissue and cell-type-specific survival dependencies in response to SAC perturbation in vivo., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
44. Inhibition of circ_0073932 attenuates myocardial ischemia‒reperfusion injury via miR-493-3p/FAF1/JNK.
- Author
-
Su Y, Zhao L, Lei D, and Yang X
- Subjects
- Animals, Humans, Rats, Cell Line, Adaptor Proteins, Signal Transducing metabolism, Adaptor Proteins, Signal Transducing genetics, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Male, Down-Regulation genetics, MAP Kinase Signaling System genetics, Myocardial Reperfusion Injury genetics, Myocardial Reperfusion Injury pathology, Myocardial Reperfusion Injury metabolism, MicroRNAs genetics, MicroRNAs metabolism, RNA, Circular genetics, RNA, Circular metabolism, Myocytes, Cardiac metabolism, Myocytes, Cardiac pathology, Apoptosis genetics, Oxidative Stress genetics
- Abstract
Oxidative stress and apoptosis play crucial roles in myocardial ischemia‒reperfusion injury (MIRI). In this study, we investigated the role of circ_0073932 in MIRI as well as its molecular mechanism. A hypoxia/reoxygenation (H/R) cardiomyocyte model was established with H9C2 cardiomyocytes, and RT-qPCR was used to measure gene expression. We observed that circ_0073932 expression was abnormally increased in the H/R cardiomyocyte model and in blood samples from MIRI patients. Inhibition of circ_0073932 suppressed H/R-induced cell apoptosis, oxidative stress (ROS, LDH and MDA), and p-JNK expression. Dual luciferase reporter assays showed that circ_0073932 targeted the downregulation of miR-493-3p, and miR-493-3p targeted the downregulation of FAF1. Furthermore, si-circ_0073932, an miR-493-3p inhibitor, oe-FAF1, or si-FAF1 were transfected into H9C2 cardiomyocytes to investigate the roles of these factors in MIRI. Our results showed that compared with the H/R group, si-circ_0073932 inhibited H/R-induced cell apoptosis, oxidative stress (ROS, LDH and MDA), and p-JNK expression. These results were reversed by the miR-493-3p inhibitor or oe-FAF1. Finally, a rat model of MIRI was established, and si-circ_0073932 was administered. Inhibition of circ_0073932 reduced the area of myocardial infarction and decreased the levels of apoptosis and oxidative stress by inhibiting the JNK signaling pathway. Our study indicated that circ_0073932 mediates MIRI via miR-493-3p/FAF1/JNK in vivo and in vitro, revealing novel insights into the pathogenesis of MIRI and providing a new target for the clinical treatment of MIRI., (© 2024. The Society for In Vitro Biology.)
- Published
- 2024
- Full Text
- View/download PDF
45. Late-onset parkinsonism in a patient with a novel frameshift THAP1 variant.
- Author
-
Courtin E, Poblete NH, Clot F, Guehl D, and Burbaud P
- Subjects
- Aged, Humans, Male, Age of Onset, Nuclear Proteins genetics, Apoptosis Regulatory Proteins genetics, DNA-Binding Proteins genetics, Frameshift Mutation, Parkinsonian Disorders genetics
- Abstract
Competing Interests: Declaration of competing interest There are no further conflicts of interest.
- Published
- 2024
- Full Text
- View/download PDF
46. β-Cell-selective regulation of gene expression by nitric oxide.
- Author
-
Naatz A, Yeo CT, Hogg N, and Corbett JA
- Subjects
- Animals, Mice, Transcription Factors metabolism, Transcription Factors genetics, Transcription Factor CHOP metabolism, Transcription Factor CHOP genetics, HSP70 Heat-Shock Proteins metabolism, HSP70 Heat-Shock Proteins genetics, Heme Oxygenase (Decyclizing) metabolism, Heme Oxygenase (Decyclizing) genetics, Cell Cycle Proteins metabolism, Cell Cycle Proteins genetics, Insulin metabolism, Proto-Oncogene Proteins metabolism, Proto-Oncogene Proteins genetics, Rats, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Membrane Proteins, Heme Oxygenase-1, Nitric Oxide metabolism, Insulin-Secreting Cells metabolism, Insulin-Secreting Cells drug effects, Nitric Oxide Synthase Type II metabolism, Nitric Oxide Synthase Type II genetics, Gene Expression Regulation drug effects, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics
- Abstract
Nitric oxide is produced at low micromolar levels following the induction of inducible nitric oxide synthase (iNOS) and is responsible for mediating the inhibitory actions of cytokines on glucose-stimulated insulin secretion by islets of Langerhans. It is through the inhibition of mitochondrial oxidative metabolism, specifically aconitase and complex 4 of the electron transport chain, that nitric oxide inhibits insulin secretion. Nitric oxide also attenuates protein synthesis, induces DNA damage, activates DNA repair pathways, and stimulates stress responses (unfolded protein and heat shock) in β-cells. In this report, the time- and concentration-dependent effects of nitric oxide on the expression of six genes known to participate in the response of β-cells to this free radical were examined. The genes included Gadd45α (DNA repair), Puma (apoptosis), Hmox1 (antioxidant defense), Hsp70 (heat shock), Chop (UPR), and Ppargc1α (mitochondrial biogenesis). We show that nitric oxide stimulates β-cell gene expression in a narrow concentration range of ∼0.5-1 µM or levels corresponding to iNOS-derived nitric oxide. At concentrations greater than 1 µM, nitric oxide fails to stimulate gene expression in β-cells, and this is associated with the inhibition of mitochondrial oxidative metabolism. This narrow concentration range of responses is β-cell selective, as the actions of nitric oxide in non-β-cells (α-cells, mouse embryonic fibroblasts, and macrophages) are concentration dependent. Our findings suggest that β-cells respond to a narrow concentration range of nitric oxide that is consistent with the levels produced following iNOS induction, and that these concentration-dependent actions are selective for insulin-containing cells.
- Published
- 2024
- Full Text
- View/download PDF
47. Protection of pancreatic beta cells against high glucose-induced toxicity by astaxanthin-s-allyl cysteine diester: alteration of oxidative stress and apoptotic-related protein expression.
- Author
-
Sakayanathan P, Loganathan C, and Thayumanavan P
- Subjects
- Animals, Membrane Potential, Mitochondrial drug effects, Cytochromes c metabolism, Tumor Suppressor Protein p53 metabolism, Tumor Suppressor Protein p53 genetics, Mice, DNA Fragmentation drug effects, Caspase 3 metabolism, Caspase 3 genetics, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Cell Line, Antioxidants pharmacology, Proto-Oncogene Proteins c-bcl-2 metabolism, Proto-Oncogene Proteins c-bcl-2 genetics, Oxidative Stress drug effects, Insulin-Secreting Cells drug effects, Insulin-Secreting Cells metabolism, Insulin-Secreting Cells pathology, Glucose toxicity, Glucose pharmacology, Apoptosis drug effects, Cysteine pharmacology, Cysteine analogs & derivatives, Reactive Oxygen Species metabolism, Xanthophylls pharmacology, Xanthophylls chemistry, Cell Survival drug effects
- Abstract
Purpose: High glucose (HG)-induced oxidative stress is associated with apoptosis in pancreatic β-cells. The protective effect of astaxanthin-s-allyl cysteine diester (AST-SAC) against HG-induced oxidative stress in pancreatic β-cells (βTC-tet cell line) in in vitro was studied. Materials and Methods: βTC-tet cell line was exposed to HG in the presence and absence of AST-SAC. Various parameters such as cell viability, reactive oxygen species generation, mitochondrial membrane potential, DNA fragmentation and expression of proteins involved in apoptosis [p53, B-cell lymphoma 2 (Bcl-2), Bcl-2 associated X (Bax), cytochrome c and caspase 3] were studied. Results: Pre-treatment of βTC-tet cells with AST-SAC (4, 8 and 12 μg/ml) in the presence of HG (25 mM) protected the viability of the cells in a dose-dependent manner. AST-SAC treatment mitigated the oxidative stress thereby preventing the mitochondrial dysfunction, DNA damage and apoptosis in βTC-tet cells against HG toxicity. Treatment with AST-SAC prevented the increased expression of p53 under HG conditions. Further, AST-SAC treatment maintained the level of pro-apoptotic (Bax, cleaved caspase-3 and cytochrome c) and anti-apoptotic (Bcl-2) proteins to that of the control level under HG exposed conditions in βTC-tet cells. Conclusion: Altogether, AST-SAC alleviated HG-induced oxidative damage and apoptosis in pancreatic β-cells by enhancing the antioxidant status and altering apoptotic-related protein expression.
- Published
- 2024
- Full Text
- View/download PDF
48. PMAIP1 promotes J subgroup avian leukosis virus replication by regulating mitochondrial function.
- Author
-
Zhao Y, Zhao C, Deng Y, Pan M, Mo G, Liao Z, Zhang X, Zhang D, and Li H
- Subjects
- Animals, Avian Proteins genetics, Avian Proteins metabolism, Mitochondrial Proteins genetics, Mitochondrial Proteins metabolism, Apoptosis Regulatory Proteins genetics, Apoptosis Regulatory Proteins metabolism, Avian Leukosis Virus physiology, Chickens, Virus Replication, Poultry Diseases virology, Poultry Diseases genetics, Mitochondria metabolism, Avian Leukosis virology
- Abstract
Avian leukosis virus Subgroup J (ALV-J) exhibits high morbidity and pathogenicity, affecting approximately 20% of poultry farms. It induces neoplastic diseases and immunosuppression. Phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1), a proapoptotic mitochondrial protein in the B-cell lymphoma-2 (Bcl-2) family, plays a role in apoptosis in cancer cells. However, the connection between the PMAIP1 gene and ALV-J pathogenicity remains unexplored. This study investigates the potential impact of the PMAIP1 gene on ALV-J replication and its regulatory mechanisms. Initially, we examined PMAIP1 expression using quantitative real-time PCR (qRT-PCR) in vitro and in vivo. Furthermore, we manipulated PMAIP1 expression in chicken fibroblast cells (DF-1) and assessed its effects on ALV-J infection through qRT-PCR, immunofluorescence assay (IFA), and western blotting (WB). Our findings reveal a significant down-regulation of PMAIP1 in the spleen, lung, and kidney, coupled with an up-regulation in the bursa and liver of ALV-J infected chickens compared to uninfected ones. Additionally, DF-1 cells infected with ALV-J displayed a notable up-regulation of PMAIP1 at 6, 12, 24, 48, 74, and 108 h. Over-expression of PMAIP1 enhanced ALV-J replication, interferon expression, and proinflammatory factors. Conversely, interference led to contrasting results. Furthermore, we observed that PMAIP1 promotes virus replication by modulating mitochondrial function. In conclusion, the PMAIP1 gene facilitates virus replication by regulating mitochondrial function, thereby enriching our understanding of mitochondria-related genes and their involvement in ALV-J infection, offering valuable insights for avian leukosis disease resistance strategies., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
49. Microglial Pdcd4 deficiency mitigates neuroinflammation-associated depression via facilitating Daxx mediated PPARγ/IL-10 signaling.
- Author
-
Li Y, Zhan B, Zhuang X, Zhao M, Chen X, Wang Q, Liu Q, and Zhang L
- Subjects
- Animals, Male, Mice, Adaptor Proteins, Signal Transducing deficiency, Adaptor Proteins, Signal Transducing genetics, Adaptor Proteins, Signal Transducing metabolism, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Apoptosis Regulatory Proteins deficiency, Depression metabolism, Depression etiology, Lipopolysaccharides toxicity, Mice, Inbred C57BL, Molecular Chaperones genetics, Molecular Chaperones metabolism, Co-Repressor Proteins genetics, Co-Repressor Proteins metabolism, Interleukin-10 metabolism, Interleukin-10 deficiency, Interleukin-10 genetics, Mice, Knockout, Microglia metabolism, Microglia drug effects, Neuroinflammatory Diseases metabolism, PPAR gamma metabolism, PPAR gamma genetics, Signal Transduction physiology, Signal Transduction drug effects
- Abstract
The dysregulation of pro- and anti-inflammatory processes in the brain has been linked to the pathogenesis of major depressive disorder (MDD), although the precise mechanisms remain unclear. In this study, we discovered that microglial conditional knockout of Pdcd4 conferred protection against LPS-induced hyperactivation of microglia and depressive-like behavior in mice. Mechanically, microglial Pdcd4 plays a role in promoting neuroinflammatory responses triggered by LPS by inhibiting Daxx-mediated PPARγ nucleus translocation, leading to the suppression of anti-inflammatory cytokine IL-10 expression. Finally, the antidepressant effect of microglial Pdcd4 knockout under LPS-challenged conditions was abolished by intracerebroventricular injection of the IL-10 neutralizing antibody IL-10Rα. Our study elucidates the distinct involvement of microglial Pdcd4 in neuroinflammation, suggesting its potential as a therapeutic target for neuroinflammation-related depression., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
50. Therapeutic targeting of ARID1A-deficient cancer cells with RITA (Reactivating p53 and inducing tumor apoptosis).
- Author
-
Wang Z, Zhang X, Luo Y, Song Y, Xiang C, He Y, Wang K, Yu Y, Wang Z, Peng W, Ding Y, Liu S, and Wu C
- Subjects
- Humans, Cell Line, Tumor, DNA Damage, Animals, Mice, HCT116 Cells, Apoptosis Regulatory Proteins metabolism, Apoptosis Regulatory Proteins genetics, Proto-Oncogene Proteins c-mdm2 metabolism, Proto-Oncogene Proteins c-mdm2 genetics, Mice, Nude, Cyclin-Dependent Kinase Inhibitor p21 metabolism, Cyclin-Dependent Kinase Inhibitor p21 genetics, Furans, Proto-Oncogene Proteins, Tumor Suppressor Protein p53 metabolism, Tumor Suppressor Protein p53 genetics, Tumor Suppressor Protein p53 deficiency, Apoptosis drug effects, Transcription Factors metabolism, Transcription Factors genetics, DNA-Binding Proteins metabolism, DNA-Binding Proteins genetics, Colorectal Neoplasms metabolism, Colorectal Neoplasms genetics, Colorectal Neoplasms pathology, Colorectal Neoplasms drug therapy
- Abstract
ARID1A, a component of the SWI/SNF chromatin-remodeling complex, is frequently mutated in various cancer types and has emerged as a potential therapeutic target. In this study, we observed that ARID1A-deficient colorectal cancer (CRC) cells showed synthetic lethal effects with a p53 activator, RITA (reactivating p53 and inducing tumor apoptosis). RITA, an inhibitor of the p53-MDM2 interaction, exhibits increased sensitivity in ARID1A-deficient cells compared to ARID1A wild-type cells. Mechanistically, the observed synthetic lethality is dependent on both p53 activation and DNA damage accumulation, which are regulated by the interplay between ARID1A and RITA. ARID1A loss exhibits an opposing effect on p53 targets, leading to decreased p21 expression and increased levels of proapoptotic genes, PUMA and NOXA, which is further potentiated by RITA treatment, ultimately inducing cell apoptosis. Meanwhile, ARID1A loss aggravates RITA-induced DNA damage accumulation by downregulating Chk2 phosphorylation. Taken together, ARID1A loss significantly heightens sensitivity to RITA in CRC, revealing a novel synthetic lethal interaction between ARID1A and RITA. These findings present a promising therapeutic approach for colorectal cancer characterized by ARID1A loss-of-function mutations., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.